Improving Teledermatology Utilization in an Alaskan Health Care System by Rowen, Mary Anne
  
IMPROVING TELEDERMATOLOGY UTILIZATION 
 
IN AN ALASKAN HEALTH CARE SYSTEM 
 
 
 
By 
 
Mary Anne Rowen, MSN 
 
 
 
A Project Submitted in Partial Fulfillment of the Requirements  
 
for the Degree of 
 
 
 
DOCTOR OF NURSING PRACTICE 
 
in 
 
Nursing Science 
 
 
 
University of Alaska Anchorage 
 
May 2019 
 
 
 
APPROVED:  
Angelia Trujillo, DNP, Committee Chair 
Lisa Jackson, DNP, Committee Member 
Molly Rothmeyer, DNP, Committee Member 
Marianne Murray, DNP, Director 
           School of Nursing 
Andre Rosay, PhD, Associate Dean 
           College of Health 
IMPROVING TELEDERMATOLOGY                                                                                     2 
Abstract 
The consistent demand for dermatology services, within an Alaskan health care network, 
warrants an organized, collaborative approach to acquiring a higher capacity of teledermatology 
consultations.  The lack of uniformity among providers for using telemedicine technology in 
dermatology can hinder cost-saving care.  Understanding the obstacles and utilization practices 
surrounding teledermatology adoption is a crucial objective for a project conducted in an 
integrated health care system.  Devising a protocol with supporting education may reinforce 
expectations for primary care providers and community health aides and practitioners to be 
consistent with the utilization of dermatology consultations.  A Teledermatology Utilization 
Project was conducted in an Alaska urban facility to affect change throughout an integrated 
system.  Results indicated a significant increase in teledermatology cases since implementing a 
protocol and supportive education. 
 
Keywords: Dermatology, Telehealth, Teledermatology, Store-and-Forward (SAF), Community 
Health Aide and Practitioners (CHA/P), Community Health Aide Program (CHAP) 
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Chapter One: Overview of the Problem  
The concept of telehealth involves the delivery of health care remotely via methods such 
as electronic mail with an accompanying image (Ford & Pereira, 2015).  It also includes 
telephone and wireless devices including cellular phones, which may or may not include video 
access (Campion, Dorsey, & Topol, 2016).  According to the American Telemedicine 
Association ([ATA], 2018), telemedicine is defined as "the remote delivery of health care 
services and clinical information using telecommunications technology" and offers no distinction 
between "telehealth" and "telemedicine" (para. 1).  It is a growing method of health care delivery 
which can positively impact the health care of numerous individuals (Campion et al., 2016). 
Using telecommunication to provide care has been an essential part of the U.S. Indian Health 
Service's (IHS) method of delivering health care since the 1970s, with the primary objective of 
improving access to health care in the setting of a limited budget while maintaining quality 
services (Kruse, Bouffard, Dougherty, & Parro, 2016).  
Though the ATA does not discriminate between the terms of telehealth and telemedicine, 
the American Academy of Family Physicians (AAFP) does offer somewhat more specific 
definitions.  “Telemedicine is the practice of medicine using technology to deliver care at a 
distance,” (AAFP, 2019, para. 4).  “Telehealth refers to a broad collection of electronic and 
telecommunications technologies that support health care delivery and services from distant 
locations,” (AAFP, 2019, para. 5).  Both concepts, however, support the practice of dermatology 
via teledermatology as it relates to the focus of this project and both terms are used throughout 
the course of this paper. 
Teledermatology is defined as “the delivery of dermatology specialty services (advice, 
diagnosis, treatment planning, and education) to patients and other healthcare providers remotely 
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using information and communication technology” (ATA, 2016, p.14).  Dermatology is 
especially compatible with telehealth, given the visibility of skin disorders, which can be 
addressed and reviewed with photographic images (McKoy et al., 2016).  The role of 
telemedicine for dermatology has been in existence since 1995 (Tensen, van der Heijden, 
Jaspers, & Witkamp, 2016).  Appropriate dermatological management is essential for wellbeing, 
cost control, and reducing health disparities (Wilmer et al., 2014).  As with the broad concept of 
telehealth, teledermatology can facilitate access to care based on geographic and socioeconomic 
status (Campagna, Naka, & Lu, 2017).  According to McKoy et al. (2016), teledermatology is a 
solution to specialty care that is not appropriately utilized despite its ability to provide quality 
care to those who are geographically disadvantaged. 
Muir (2014) identified several other advantages of teledermatology, such as decreasing 
the burden of clinic demand, expediency, and avoiding higher priced visits for in-person 
dermatology consultation.  Campagna et al. (2017) asserted there was less time involved in 
teledermatology consultation allowing greater provider productivity.  Encounters done in a 
virtual capacity could circumvent the potential to miss appointments, since accessibility to a 
dermatological specialist is easily facilitated electronically (Naka, Lu, Porto, Villagra, Wu, & 
Anderson, 2018).  
The expense of skin disease is also noted throughout the literature.  The cost of 
dermatological care in the United States was estimated at $75 billion in 2013; however, when 
factoring in productivity issues, the cost was closer to $96 billion, and cost per patient was $240 
(Lim et al., 2017).  Campagna et al. (2017) maintain teledermatology provides cost savings by 
minimizing salary loss from missed work and the cost of travel.  Another particular benefit of 
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teledermatology is that it facilitates the education of primary care providers (PCPs) who can 
receive the dermatologist's diagnosis and recommendations (Wilmer et al., 2014).  
Despite the overwhelming potential for teledermatology, this highly functional 
application is underutilized in the dermatology field.  According to Muir (2014), few skin 
conditions necessitate in-person dermatological evaluation; though many patients sent for 
dermatology consultation could have received more timely care via teledermatology consult 
(McKoy et al., 2016).  The dermatology clinic of a particular health network reviews 
approximately nine teledermatology cases per week (S. Freeman, personal communication, 
September 15, 2017).  Generally, it may take three to six weeks for patients to receive an in-
person consultation.  Even though teledermatology has been available to this health care system 
for decades, only a small percentage of patients are evaluated and treated in this capacity, with 
many of them traveling extended distances for these visits.  Knowing that few conditions require 
an in-person consultation, it is apparent that teledermatology is not used to the extent that it 
could be to promote the benefits of the service. 
Barriers to the use of teledermatology have been identified in the literature; for example, 
providers may have a knowledge deficit regarding the actual existence of this technology (Muir, 
2014).  Additionally, a variety of solutions were also identified in the literature, including 
education and portable devices.  Understanding the unique features of  PCPs and community 
health aides and practitioners (CHA/Ps) could be beneficial in providing a strategy for higher 
utilization of technology designed to improve care.  Ultimately, a dedicated approach to skin 
care, diagnosis, and management for the patient via teledermatology will enhance the 
dermatological management for recipients of dermatological care.    
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Problem Statement 
Teledermatology is an underutilized function of providers within a prominent Alaskan 
health care system, contributing to the burden of cost, efficiency, and quality of care.  
Maximizing the use of dermatological telehealth is a significant quality improvement initiative 
which would result in cost savings to patients and the health care facility while maintaining safe 
and effective services.  Understanding the unique background and clinical practice unique to the 
health care system of focus, assists in the development of the problem question and a process for 
quality improvement.   
Background 
Alaska is home to more than 150,000 tribal affiliates, among 229 tribal groups within the 
state (Alaska Native Health Board [ANHB], n.d.).  The population associated with the tribal 
network includes an area of nearly 600,000 miles (ANHB, n.d.).  According to the Alaska 
Department of Labor statistics, there were 143,367 American Indian/Alaska Native (AI/AN) 
individuals residing in Alaska in 2014 (Alaska Native Epidemiology Center [ANEC], 2016).  Of 
this population, approximately one-third live in Anchorage and the Matanuska-Susitna areas 
(ANEC, 2016).  Only those AI/AN beneficiaries residing within the designated Anchorage 
municipality (which includes five residential areas) receive primary care within a centralized 
facility on the main health care campus (S. Freeman, personal communication, September 22, 
2017), where teledermatology may not have as high of a need as the remaining state population 
of customers (beneficiaries).  The tertiary facility which houses specialty clinics, including 
dermatology, also provides care to recipients throughout the state.  Also, stand-alone clinics 
established for the AI/AN communities were established throughout the state to provide regional 
care to residents.  Many communities in Alaska are only accessible by plane, and these 
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communities are associated with unique service unit hubs.  Telehealth can be the solution to 
access problems for many individuals residing in challenging areas (McKoy et al., 2016). 
Telehealth is accommodated through a specific software system called Alaska Federal 
Health Care Access Network (AFHCAN) which has been used in Alaska since 2001 (Carroll et 
al., 2011).  AFHCAN has been useful in primary and specialty care arenas, especially Ear-Nose-
and-Throat (ENT) (Carroll et al., 2011).  There are approximately 200 telemedicine units 
deployed throughout tribal network clinics in Alaska (S. Freeman, personal conversation, 
October 02, 2017).  AFHCAN may be assessed via the internet or mobile devices (Alaska Native 
Tribal Health Consortium [ANTHC], 2015).  Typically, teledermatology involves various 
methods of delivery: store-and-forward (SAF), video conferencing, and a combination of the two 
(McKoy et al., 2016).  The SAF modality involves transmitting a photographic image with 
supporting details for consultation purposes (McKoy et al., 2016).  According to recognized 
industry guidelines, information deemed as protected health information should be treated as 
such, in line with standard practice, and facility staff employed in technology should be aware of 
security requirements (ATA, 2016). 
Provider barriers to telemedicine and teledermatology acceptance are problematic and 
well documented.  According to Cassels and Zuehlke (2017), physicians were hesitant to use this 
application because they perceived that patients were not ready to participate in teledermatology 
and preferred in-patient visits.  Muir (2014) noted that using teledermatology services places far 
more responsibility on the PCP, as interventions generally deferred to the specialist (i.e., 
procedures, medications, and education) would now be the responsibility of the referring 
provider.  Campagna et al. (2017) noted that inadequate reimbursement for providing 
teledermatology services was also seen as a challenge to teledermatology.   
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Clinical Significance 
According to Wilmer et al. (2014), one-third of Americans experience a dermatological 
illness.  Most patients with a skin condition will first contact a non-dermatology provider 
(Wilmer et al., 2014), even though dermatological conditions are more accurately diagnosed by 
dermatology providers (Nelson et al., 2016).  Using teledermatology at the early onset of skin 
disease would not only be cost-effective and convenient but would result in better treatment 
outcome.  
Due to the insufficient number of dermatologists in the United States, patients are waiting 
for more extended periods to be treated (Campagna et al., 2017), and future shortages of 
dermatology providers can be expected (Wilmer et al., 2014).  In the dermatology clinic within 
this Alaskan health care network, there were 3,509 dermatology encounters in 2013; 3,807 
encounters in 2014; 4,928 in 2015; 4,626 in 2016 and 5,422 in 2017.  These figures include SAF 
encounters; 110, 122, 242, 250 and 253 respectively (S. Freeman, personal communication, 
March 19, 2018).  With this information, the volume of patient encounters can be appreciated 
when considering teledermatology as an option.  Utilization of teledermatology can also be 
assessed regarding percentages of overall care, typically 4%, according to historical aggregate 
data.  
Current Practice 
The consistent demand for dermatology services warrants an organized, collaborative 
approach to increase the number of teledermatology referrals and reduce the number of 
unnecessary in-person referrals.  There is a wide variation among PCPs in this network as to 
when a patient should be referred and whether these referrals are completed via teledermatology 
or in-person.  There are currently no established facility protocols to guide PCPs in selecting 
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cases for teledermatology SAF versus in-person consultations; however, there are technical and 
clinical guidelines established by the ATA  (McKoy et al., 2016).  PCPs use the teledermatology 
software at their discretion and comfort level. 
Another caveat of clinical practice in this health care network is that referrals are sent to 
specialty clinics by one of several methods.  First, local providers send local patients for 
specialty services.  These patients are often scheduled for in-person visits.  Second, local patients 
are referred by other specialty providers or emergency department providers.  Third, out-of-area 
patients are often referred by providers who either oversee the clinic or are positioned in remote 
areas.  Lastly, rural patients in town to see other specialists are often referred to the dermatology 
provider while visiting locally.  These patients may have immediate needs associated with 
oncological or surgical care and customarily referred to a dermatology provider while they are in 
town.  Such a process is challenging, however, if all clinic appointment times are full, especially 
with non-urgent cases or with patients who do not keep appointments.   
Consultations among providers who would like assistance are often done on a "curb-side" 
approach, through electronic mail (e-mail), secured texting, phone consultation, or by face-to-
face examination of the patient in a nearby room.  There is no direct method to bill for these 
interprofessional interactions.  The preferred method for consultation from distant locations has 
been through AFHCAN.  
Typically, teledermatology consultation cases originate in the service unit hubs or village 
clinics.  Images are taken, and the history is obtained, which may be initiated by CHA/Ps and 
endorsed by PCPs.  Cases are then sent to the tertiary facility for dermatology review.  
Routinely, a response is made to the service unit with recommendations and diagnosis within 24 
to 72 hours.  The wait time for an in-person dermatology visit, with two full-time providers, has 
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been four to six weeks; and with a third provider working three-quarters time, the wait is 
approximately two to three weeks (A. Kapotak, personal communication, September 22, 2017).  
The dermatology providers at the urban tertiary facility are the only dermatology providers for 
this network.  There are telehealth coordinators who can reach out to the various service units to 
support teledermatology needs.  
During the period January to August 2017, there were 195 SAF dermatology cases, the 
majority of which originated from a select few service units (S. Freeman, personal 
communication, September 22, 2017).  One particular regional corporation with road access to 
Anchorage is a consistent user of teledermatology.  During the 2017 calendar year (January to 
August), 77 teledermatology cases originated from this facility.  In contrast, one of the rural 
regional sites only sent four teledermatology cases.    
Statistics from the 2017 calendar year show 3,461 dermatology outpatient encounters (S. 
Freeman, personal communication, September 26, 2017) (not including SAF).  Of the 3,461 
patient visits, 2,166 visits were by patients in Anchorage or the general proximity, and 1,295 
from outside the immediate area (S. Freeman, personal communication, September 22, 2017).  
Presumably, many of these visits could also have been seen by the SAF technology, but patients 
will often drive into Anchorage if they reside in a community with a road system to the city.    
Clinical Practice Question 
    PICOT question. Would providing teledermatology education and protocols for  PCPs and 
CHA/Ps increase utilization of teledermatology over three months?  Because quality 
improvement for teledermatology utilization is the intended purpose of this doctoral project, 
focusing on methods and strategies to promote provider appreciation of teledermatology for 
patients with skin related disorders can result from accomplishing this objective.    
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Population (P). The population for the project was PCPs and CHA/Ps who provide care 
to beneficiaries who live outside of the Anchorage area.  Providers located in distant and 
logistically challenging regions have the most excellent opportunity to impact patients to a 
greater degree with teledermatology services.  The total minimum number of potential subjects 
collected from multiple resources is estimated at 1000 providers.  This estimation includes the 
number of CHA/Ps in this health care system which is estimated to be 550 individuals (Alaska 
CHAP, n.d.).  The actual number of subjects included in the project, following institutional 
approval, was 311 providers.  
Intervention (I). A survey was disseminated to service units throughout the network who 
have accepted participation in the project.  The survey was sent via Listserv to the appropriate 
provider groups and CHA/Ps.  This baseline tool was created to identify practice and knowledge 
gaps in the use of teledermatology SAF.  Understanding impediments to teledermatology 
provides insight on how service units with the steadiest use maintain this high-level consistency, 
as opposed to those with far lower utilization rates.  The highest using regional facility has been 
a consistently high user for the last three years.  Conceivably, utilization may be associated with 
the connectivity of providers to the culture and the patients.  According to Kruse et al. (2016), 
cultural awareness is a supreme quality in telehealth care delivery within the Native American 
culture, and telemedicine should be modified to accommodate the cultural climate.  
Following the survey, an educational module was developed to discuss teledermatology.  
The intent was to provide education, support, and connectivity.  Addressing skin illness from a 
systematic approach is necessary and could likely lessen delay in treatment, promote quality of 
life and minimize health disparities often seen in populations that reside remotely (Wilmer et al., 
2014).   
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The concept of standardizing teledermatology throughout a system is elusive in literature; 
however, there are several pragmatic reasons why this would be advantageous to the patients 
served within the system.  Such reasons include access to care, cost-reduction, and timeliness 
(Kruse et al., 2016).  The ATA has developed clinical practice guidelines for dermatology to 
guide providers in the appropriate use of teledermatology (McKoy et al., 2016).  The authors 
noted the guidelines are applicable to many types of health care facilities (McKoy et al., 2016).   
Guiding providers within a network to use this system requires a unique kind of protocol or 
guidance from an administrative position.  This guidance could establish expectations for PCPs 
to initiate consultation for dermatology support versus referral to dermatology.  PCPs should at 
least have the option to use consultative services if they exist.    
Guidelines, in general, yield opportunities for specialists to give recommendations for 
submission of consults for a variety of skin conditions.  Special equipment or attention may be 
warranted for full body assessments, hair-bearing areas, pigmented lesions, skin tone, and 
mucosal areas (ATA, 2016; McKoy et al., 2016).  Though protocols can incorporate guidance in 
such areas, at a minimum, establishing a concrete visual consult and referral pathway provides 
practical direction for potential users.  
Following the consult and referral workflow expectations, creating education regarding 
teledermatology was the final portion of the intervention.  The educational module was based on 
literature and surveys to encourage providers and to consult via the established software.  
Responses and comments from surveys addressed knowledge gaps and concerns and presented 
opportunities for PCPs and CHA/Ps to discuss what is not working well and what may help other 
providers and service units.  All such information was valuable feedback for the dermatology 
and telemedicine department.   
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Comparison group (C). The comparison group was utilization data before intervention 
and post-intervention.  Information may be obtained from existing aggregate data of 
teledermatology utilization.  These records reflect the teledermatology practices before the 
institution of guidance. 
Outcome (O). The primary outcome goal for this project was an anticipated overall 
increase in teledermatology SAF consultations.  Such an expected rise reflects the adoption of 
teledermatology by PCPs and CHA/Ps.  Additionally, as the adoption of the technology 
advances, further expansion of utilization is projected.  In-person referrals from distant and 
remote communities should decrease while SAF cases increase.  Because of such outcomes, the 
appointment times in the clinic will be more flexible to allow for treatments best rendered by 
experienced dermatology providers, as well as hospital consults and urgent issues.    
Time (T). Changes to an existing system were gradually implemented.  Collecting 
preliminary utilization information and introducing a method to guide providers in the use of 
teledermatology was done following the completion of an internal review board process (IRB).  
The evaluation was completed three months following implementation.  A timeline was 
developed and constructed to monitor progress and maintain project trajectory. 
Conclusion 
For many dermatological cases, teledermatology is an appropriate methodology for 
improving dermatological health care.  Judicious consideration of this process could increase 
consultations, as teledermatology becomes more acceptable for appropriate conditions and 
patients.  Introducing a method which primary providers could accept and sustain is rewarding 
for the patients and the entire health care network.  The patients will have access to quality care 
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in their local environment, costs will decrease, and providers will be more educated regarding 
dermatology conditions and potentially be more involved with their patient's care.    
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Chapter Two: Review of the Literature 
The numerous benefits of teledermatology, including improved access to care, cost 
savings (Campagna et al., 2017) and timely evaluation through examination of images, have 
been identified (Ford & Pereira, 2015).  Due to the extended wait times to see a dermatology 
specialist, this commodity is particularly valuable (Nelson et al., 2015).  The advantage of 
providing education to providers can eventually augment the types of cases submitted for 
dermatological expertise (Barbieri, Nelson, Bream, & Kovarik, 2015; Ford & Pereira, 2015; 
Vyas et al., 2017).  Ford and Pereira (2015) noted the mechanism for teledermatology permits 
greater ease of consultation; therefore, more cases can be sent for teledermatology review, 
sparing PCP of trial and error.  Nelson et al. (2016) noted dermatologists and general 
practitioners often have a significant disagreement for both diagnosis and treatment plans for 
most skin conditions, favoring the dermatologist for greater accuracy.   
Teledermatology has been associated with numerous positive benefits, and it has the 
capacity for much greater use.  Presently, there is potential for higher integration into primary 
care practice, specifically those affiliated with the Alaskan health care system.  The purpose of 
this literature review is to identify and synthesize findings that may help to improve the 
teledermatology process for the AI/AN population in Alaska.     
Clinical Questions  
1.  What are the barriers to teledermatology utilization in this Alaska health care system? 
2.   How can obstacles to teledermatology utilization be minimized?  
3.  Can the implementation of local utilization protocols and education on 
teledermatology improve the use of teledermatology?  
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Methodology 
The literature search was conducted through the University of Alaska Anchorage 
Consortium Library and databases such as PubMed, CINAHL, and Google Scholar.  
Methodology for searching literature involved attempts to search for barriers and guidelines in 
teledermatology.  Search terms included: "telemedicine," "telemedicine Alaska," 
"teledermatology," "teledermatology and acceptance," "teledermatology barriers," 
"implementing a process for improvement of telehealth," "teledermatology Veterans 
Administration," "teledermatology guidelines," "teledermatology protocols," "underserved 
populations," and "telemedicine and Native American."  Limits included: "systematic review" 
"meta-analysis," "observational study," "practice guidelines," "full-text," and "published within 
the last five years."  PubMed search was the most useful database for the topic of 
teledermatology.   
Strategies. With the use of these search terms, articles were filtered by date, titles, 
cultural relevance, and reviewed for applicability.  If titles were deemed applicable, abstracts 
were then reviewed.  The majority of literature was accessed through PubMed.  Of these, 15 
articles were examined to determine relevance to the problem question.  Two of these were 
identified as more appropriate for background information, and 11 were accepted for the 
literature review.  Though a generous amount of information on telemedicine exists, locating 
studies which were pertinent to the scope of teledermatology and the needs of the Alaska Native 
population was a challenge.  The literature focused on publications regarding both, telemedicine 
and teledermatology.  Themes pertinent to the problem question were identified.  Articles which 
addressed these themes were selected for critical appraisal for the literature review. 
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Data evaluation.  The 11 articles were scanned for elements that addressed barriers and 
methods for overcoming these barriers.  Although this subject was common, information about 
guidelines and protocols was more elusive.  For many articles, information about these themes 
was not exclusively the main topic of the study but was included as background information.  
Some items contained only a small amount of detail associated with the proposal topic themes 
but were still included in this review.  Due to limited literature addressing the barriers and 
remedies to teledermatology and the concept of standardization, articles that supported the 
problem questions were included in the literature review. 
Critical Appraisal  
The critical appraisal worksheet from University of New South Wales (UNSW) Australia 
(Bennett & Thompson, 2013) was used for quantitative studies, and the Melnyk and Fineout-
Overholt, as cited by Powers (2015) was used for the qualitative studies.  Literature review 
articles were appraised with the Critical Appraisal Skills Programme worksheet (University of 
Glasgow, n.d.).  The Dearholt and Dang, (as cited in Spiva, 2013), Johns Hopkins evidence 
rating scales (Newhouse, Dearholt, Poe, Pugh, & White, 2005) and Stillwell, Finout-Overholt, 
Melynk, & Williamson (2010) scales were used to evaluate the strength and quality of the 
evidence.  Strength was rated using a scale of one through seven, with one indicating the highest 
level and seven, the lowest (Stillwell et al., 2010).  The quality was rated on an A-C level; ‘A' 
indicated the highest quality and ‘C' the lowest.  The concept of best practices aligns with the 
strength and quality of evidence (Dearholt & Dang, as cited in Spiva, 2013).  The articles 
included in this study were assigned a level of strength and quality, represented by the number 
and letter.  The results of the evaluation of the 11 articles chosen for inclusion are indicated in 
Table 1.   
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Table 1 
Strength and Quality of Evidence 
                                           Strength of Evidence 
Quality of 
Evidence   
1 2 3 4 5 6 7 
A - n=1 n=2 - n=3 - - 
B - - n=2 - n=1 n=1 - 
C - - - - n=1 - - 
 
Analysis. Of the 11 qualifying articles, four addressed telemedicine in general with one 
emphasizing dermatology, and seven articles were specific to dermatology.  Two of the articles, 
one quantitative and one qualitative, addressed the Native American population which is a 
significant factor in the proposed project (Hiratsuka, Delafield, Starks, Ambrose, & Mau, 2013; 
Kruse et al., 2016).  As part of the critical appraisal, strengths and limitations were evaluated.  
Per Melnyk and Fineout-Overholt (2015a), the primary components to critical appraisal are 
validity, reliability, and relevance to the population.  Overall, all 11 studies demonstrated validity 
and reliability; the chief element was the applicability to the patient population identified in the 
problem question.    
Five of the evidenced-based literature articles were systematic literature reviews, though 
only one of these contained enough randomized control studies, and therefore, assigned a level of 
evidence strength as a two (Mounessa et al., 2017).  One article provided quantitative data in 
ranking order for variables such as cost, access, and quality (Kruse et al., 2016).  The narrative 
review by Tensen et al. (2016) was very informative and contained a significant amount of 
literature.  The remaining six articles included case-control studies, case studies, surveys, time 
series analysis, focus groups and expert reporting from the Veterans Health Administration 
(VHA). 
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Strengths.  Each article used in this literature review possessed unique strengths.  All 
articles supported the review and the critical use of teledermatology.  Tensen et al. (2016) 
discussed the Teledermatology Technology Acceptance Model (TAM), or modified TAM-
(Orruño, Gagnon, Asua, & Ben Abdeljelil, 2011) which has value in addressing the problem 
question with PCPs of this integrated health system.  Mounessa et al. (2017) provided a robust 
literature review of global studies, concluding that providers were, overall, satisfied with 
teledermatology.  The systematic review by Trettel, Eissing, and Augstin (2017) focused on 
international dermatology.  One-fourth (n=56) of the studies were published in the United States. 
Additionally, Landow, Mateus, Korgavkar, Nightingale, and Weinstock (2014) noted specific 
elements to be considered in a teledermatology program, which could be a useful part of 
protocols or guidance development.   
Barbieri et al. (2015) discussed teledermatology by using the mobile app, which was one 
of the first studies to address this modality.  The mobile app could be an important consideration 
when contemplating decreasing barriers.  Vyas et al. (2017) identified license issues related to 
reimbursement and acknowledged barriers and possible remedies to the teledermatology 
adoption problem.  Landow, Oh, and Weinstock (2015) provided original research and was the 
first to focus on VHA teledermatology programs.  The VHA is an integrated system with similar 
features as the health network in this project.  Piccoli, Amorim, Wagner, and Nunes (2015) 
recognized that teledermatology could spare unnecessary dermatology referral in the setting of 
skin cancer concern.   
Kruse et al. (2016), as well as Hiratsuka et al. (2013), provided a cultural perspective for 
the use of telehealth, which is applicable across different populations.  The authors offered 
additional views on the patient-provider relationship that is vital for the integrity of a telehealth 
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program.  Taylor, Coates, Wessels, Mountain, and Hawley (2015) developed a framework to 
promote the adoption and improvement of telehealth.  Additionally, they demonstrated the 
benefit of using case studies and action research to support practice improvement as well as 
institute structure to a telehealth program (Taylor et al., 2015).    
Limitations. Though each article demonstrated strengths; limitations were noted or 
acknowledged throughout the review.  Trettel et al. (2017) recognized the possibility for 
publication bias since the articles selected might have positively presented teledermatology.  
Kruse et al. (2016) reviewed the literature to ascertain the advantages of teledermatology and 
discussed cost, quality, and access and concluded there was substantial research on access, and a 
lack of research on quality of care and cost.  Mounessa et al. (2017) acknowledged there was no 
universality when reporting provider satisfaction and Barbieri et al. (2015) also noted limitations 
based on the small sample size.  Vyas et al. (2017), in general, does not acknowledge limitations 
but concedes to the minimal randomly controlled studies available.     
Limitations to the VHA study were associated with potential data entry flaws and 
encounter errors (Landow et al., 2015).  Landow et al. (2014) also acknowledged a need for 
better evaluation of teledermatology programs to evaluate access and savings associated with in-
person appointments.  Additionally, clinical data and information about quality were not 
included in the Telehealth Workload Cube used by the VHA (Landow et al., 2015).  Hiratsuka et 
al. (2013) acknowledged limitations including small sample size, as well as the inclusion of 
participants, who were not representative of the larger population, as most were college 
educated.  These authors identified the existence of potential cultural differences between Native 
Hawaiian and Native Alaskan.  Piccoli et al. (2015) recognized only one dermatologist was 
evaluating the images of this study.  The study by Tensen et al. (2016) used only one database 
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and one reviewer.  Finally, Taylor et al. (2015) reported there was some conflict in use of some 
control methods, mainly since the study used ever-progressing commodity, such as technology.  
Synthesis. All articles involved in this literature review demonstrated some degree of 
merit to address the clinical practice problem; though the focus of these articles may not have 
discussed them directly.  The main themes extrapolated from the literature review included: 
barriers to teledermatology, overcoming these barriers, and establishing structured protocols for 
guidance.  These elements are discussed below. 
Theme I: Barriers. Approximately seven articles addressed barriers to 
telemedicine/teledermatology.  Issues with the equipment, imaging, internet, and technology 
were discussed throughout most of the literature (Barbieri et al., 2015; Hiratsuka et al., 2013; 
Kruse et al., 2016; Mounessa et al., 2017; Taylor et al., 2015; Vyas et al., 2017).  Taylor et al. 
(2015) also noted several barriers to the implementation of telehealth in an organization, 
including data sharing, insufficient resources to execute the activity, inadequate staff 
involvement, and uncertainty of appropriate candidates for telehealth (Taylor et al., 2015).  Vyas 
et al. (2017) noted potential infrastructural problems such as sustaining telehealth in the event of 
a natural disaster.  Vyas et al. (2017) also noted additional barriers including issues with the 
capture of images; specifically, with regards to the depth of certain skin conditions. 
Cost and reimbursement were also identified as barriers to teledermatology and telehealth 
utilization (Kruse et al., 2016; Mounessa et al., 2017; Tensen et al., 2016; Vyas et al., 2017).  
According to Vyas et al. (2017), reimbursement is tied to documentation that is associated with 
the elements of an in-person physical exam.  If there is less reimbursement, due to the nature of a 
telehealth exam, less money is received from investing in the technology (Vyas et al., 2017). 
This view was similarly shared by Kruse et al. (2016).  Vyas et al. (2017) also noted medical 
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licensure laws might not reflect the currency of technological advances in health care, posing 
additional barriers for the use of telemedicine (Vyas et al., 2017).    
Increased demand for workload, workflow changes, and time consumption were 
frequently mentioned as barriers to the use of teledermatology (Barbieri et al., 2015; Landow et 
al., 2015; Mounessa et al., 2017; Taylor et al., 2015).  Security and privacy issues were also 
identified (Barbieri et al. 2015; Tensen et al., 2016; Vyas et al., 2017), as well as an 
unwillingness to adapt to change (Kruse et al., 2016).  Tensen et al. (2016) and Barbieri (2015) 
discussed legal issues in using teledermatology; while Tensen et al. (2016) argued the degree of 
provider satisfaction could be associated with provider adoption.  Another potential barrier 
included is the time required to train staff in the use of teledermatology.  The absence of skin 
palpation as part of the examination may also inhibit providers from using this (Tensen et al., 
2016).      
Theme II: Overcoming barriers. The literature search addressed several strategies to 
overcome the obstacles to teledermatology, including technology support, use of mobile phones 
and portable devices (Barbieri et al., 2015; Hiratsuka et al., 2013; Kruse et al., 2016; Mounessa 
et al., 2017; Vyas et al., 2017).  Barbieri et al. (2015) noted the use of a mobile phone was the 
solution for barriers such as workflow disruptions, equipment issues, and imaging problems. 
Vyas et al. (2017) discussed the addition of portable devices (such as Google Glasses) might aid 
in ease of use of telemedicine and also reduce the size of accommodations needed for 
telemedicine. 
Taylor et al. (2015) provided many recommendations for improving telemedicine 
practices.  Promoting access between software and the electronic health record was 
recommended, as well as acquiring financial support for telemedicine (Taylor et al., 2015).  
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Evaluating staff proficiency, as well as promoting and educating dedicated staff was additional 
recommendations (Kruse et al., 2016; Taylor et al., 2015).  Additionally, Kruse et al. (2016) also 
noted other improvements including the reimbursement for cultural interventions, such as 
traditional healing and spiritual modalities and culturally appropriate telemedicine practices. 
The expansion of health insurance to cover the telemedicine costs to recoup needed 
telemedicine funding would promote costs (Kruse et al., 2016).  Modification of licensure laws 
to permit licensing of providers across state lines instead of only licensing within the state of the 
consulting provider would diminish some of the barriers to telehealth (Vyas et al., 2017).  Such 
concessions would promote adequate reimbursement, which would also support the cost of 
equipment (Vyas et al., 2017). 
Tensen et al. (2016) discussed the value of a business model in the adoption of 
teledermatology practices.  This model includes five necessary steps: (a) understanding the 
organization's manner of rendering care; (b) determining alternative methods of care and the 
cost; (c) having the support from the organization; (d) creating a plan; and (e) educating and 
training staff.  Landow et al. (2015) acknowledged successful implementation of 
teledermatology required support from the organization.  Instituting performance measures for 
the adoption of telehealth was addressed as an incentive for users, as well as a training program 
established for teledermatology (Landow et al., 2015).  Both Landow et al. (2015) and Hiratsuka 
et al. (2013) acknowledged the need for support staff for telemedicine/teledermatology.  Trettel 
et al. (2017) advocated for the placement of financial protocols and financial procedures as vital 
to assimilating this practice into the day to day routines. 
Theme III.  Protocols. Little was discussed in the literature on the topic of health 
network standardization of teledermatology and recommended local protocols or processes.  
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Vyas et al. (2017) noted the need to improve existing processes and add new programs for 
telemedicine.  Barbieri et al. (2015) suggested a potential liability for providers if they avoid 
teledermatology for care when it is available, which could result in a delay of diagnosis and 
treatment.  Piccoli et al. (2015) discussed the establishment of teledermatology-specific protocols 
for suspected cancerous lesions and supported the use of the protocol for images when skin 
cancer is a concern.  The authors reported a reduction of inappropriate consults through the use 
of a protocol (Piccoli et al., 2015).  Taylor et al. (2015) suggested making referral/discharge 
telemedicine plans standardized by establishing a "telehealth pathway" (p. 5), and Hiratsuka et 
al. (2013) indicated it was important for the first appointment to be in-person and for patients to 
have the same provider on follow-up encounters.  Additionally, Tensen et al. (2016) 
acknowledged there should be standardization for equipment requirements and imaging 
requirements.  Barbieri et al. (2015) identified which dermatological conditions were amenable 
to teledermatology and which were not, which could be part of protocol development. 
Landow et al. (2014) discussed elements of a teledermatology program that would 
promote the reduction of in-person visits.  These include (1) pre-selectivity of patients for 
teledermatology, (2) taking good pictures, (3) using teledermoscopy, and (4) promoting 
infrastructure and culture that align with the program goals.  Pre-selection involves categorizing 
the referral.  For example, a category may include referrals sent by PCPs but screened by a 
dermatologist.  Selections can also be determined by a team which consists of a dermatology 
provider or a PCP with training in dermatology.  Other categories may be included or exclude 
various conditions.  Quality imaging is particularly germane to the scope of teledermatology and 
requires training, as well as guidelines.  In addition to appropriate pictures, teledermoscopy (a 
tool to help provide diagnostic confidence) can increase reliability and ultimately reduce 
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unnecessary in-person visits.  Lastly, the organizational infrastructure is the ability of the 
organization to manage patient care without a dermatologist when care beyond the skills of the 
teledermatology provider is needed.  Culture, in the professional sense, refers to the receptivity 
of providers to use teledermatology and receive recommendations (Landow et al.,  2014).  
Clinical guidelines for teledermatology should be in place to promote confidence for 
patients (Trettel et al., 2017).  Landow et al. (2015) reported standardized operational manuals 
had been developed, and SAF templates are available for use by the provider, imager, and the 
reader.  Additionally, the VHA system ensures every VHA clinic applies the same standards to 
support quality and sustainable teledermatology program (Landow et al., 2015).    
Limitations 
Overall, there was a disparity in the literature supporting the need for protocol practices 
for unique health care networks, populations, and geographical locations.   
Moreover, there was a lack of evidence suggesting the provision of directives by the organization 
can produce outcomes associated with the known benefits of teledermatology such as improved 
access, timeliness, cost-effectiveness, and enhanced quality of health care.  Evidenced-based 
literature specific to the AI/AN population regarding telemedicine was also minimal.  
Conclusion 
Teledermatology has a widely accepted role in telemedicine and the dermatology field. 
The benefits are well recognized, and currently, research is limited regarding widespread 
implementation and provider engagement.  Barriers to the use of telemedicine were presented 
throughout the literature, with many recommendations on overcoming some of these 
impediments.  The identification of obstacles may be purposeful in guiding protocol 
development as well as the reasons for impediments to teledermatology use, although there may 
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be other barriers yet to be recognized.  Development of an efficient, quality, and structured 
process using teledermatology within a complex system was not found in the literature.  This 
health care network has many features that would make teledermatology a robust utility, 
increasing quality and decreasing cost; however, widespread adoption is hindered by obstacles 
and barriers still to be identified and reconciled.  Once this has been accomplished, an accurate 
systematic approach to teledermatology guideline/protocol processes can be implemented.      
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Chapter Three: Organizational Framework 
Teledermatology is a specialty form of telemedicine, currently practiced within an 
Alaskan integrated health care system to provide remote dermatological care to patients residing 
in urban and rural areas throughout the state.  Low levels of utilization teledermatology among 
providers within the health care system have been the focus of this quality improvement project.  
The Stetler Model of Evidenced Based Practice is a functional model for the proposed initiative 
to advance teledermatology utilization within this unique Alaskan health care system.  The health 
care system consists of many geographically dispersed facilities which ultimately receive 
specialty care from one urban tertiary center.  Adherence to the Stetler Model may guide the 
development of "new policies, procedures, protocols, programs and standards" (Dang et al., 
2015, p. 282) regarding teledermatology practice, which are the ultimate objectives of this 
project.      
Evidenced Based Practice Model 
The Stetler Model of Evidenced-Based Practice (SMEBP) is designed for the nurse 
practitioner's unique relationship with evidenced-based practice (Stetler, 2001), Figure 1.  
Though modified several times, the most recent revision became associated with evidenced-
based nursing practice (Dang et al., 2015).  As currently written, the SMEBP is an appropriate 
and suitable model for this project.  Figure 1 below depicts and describes the useful and practical 
stage SMEBP (Stetler, 2001).   
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Figure 1. Stetler Model of Evidenced Based Practice. The SMEBP is comprised of a sequence of 
five stages, guiding the nurse practitioner toward goal of practice change. Stetler (2001). 
           
            Beyond the stages supporting this evidenced based model, the revised SMEBP includes  
 
six unique assumptions (Stetler, 2001).       
     
1. An individual’s use of research may be involved at the organizational level.  
 
2.  There are three types of research utilization: instrumental, conceptual and symbolic; 
moreover, one or more can be involved.  
3.  Decision-making can occur by blending research conclusions with other types of 
information. 
4.  Perspectives and utilization of evidence are influenced by both internal and external 
dynamics. 
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5.  Research and subsequent assessment result in only likelihoods, not definite 
conclusions. 
6.  Research utilization and evidenced-based practice knowledge and competence deficit 
can result in ineffectual use (Stetler, 2001).   
Using evidence in a stepwise fashion will improve the practice of teledermatology as it 
exists currently within this system. This project entails the exploration of barriers and solutions 
to teledermatology adoption.  This action followed by the establishment of systematic guidelines 
for use within the network, and the Stetler Model supports the application of evidence, including 
consensus guidelines, in a variety of ways (Dang et al., 2015). 
Steps of the Stetler Model in Support of the Teledermatology Utilization Project  
Dang et al. (2015) describe the five stages of the SMEBP, presented in a step-wise 
fashion.  The sequence is described below concerning the teledermatology utilization project.  
The project followed the direction of these steps to fully support the project completion and 
success. 
Phase I: Preparation. This initial step involves prioritization, assessment, organization, 
and searching for evidence (Dang et al., 2015).  One significant aspect of this step is to identify 
the problematic areas of the internal evidence.  Internal evidence is information that can be 
obtained on a local scale (Dang et al., 2015).  This evidence has been casually observed in the 
clinic setting.  With the current practice, providers within the network have the option of using 
teledermatology or referring the patient to the dermatology clinic.  At present, there are a 
disproportionate number of patients seen in clinic versus telemedicine, despite the vast 
geographical area assigned to the dermatology clinic at this urban tertiary health care facility. 
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Understanding barriers to provider utilization are one of the main foci of the project.  
According to Tensen et al. (2016), there are numerous barriers to teledermatology practice.  
Some of these barriers, however, are not applicable to this group of providers given the unique 
features of the health care system, namely direct reimbursement.  Additionally, practice 
limitations are another potential problem, as providers must be licensed in the state of the 
consultation (Lowie, 2012).    
Although the resource of teledermatology is widely available throughout the health care 
network, there are several reasons many providers in the health care system do not use the 
technology.  Specific reasons for not utilizing the service may include those cited in the 
literature, but others are likely to exist.  Further exploration would require the collection of 
additional internal evidence.  For this purpose, creating a survey instrument was a reasonable 
method of acquiring additional internal evidence.  The survey was developed with existing 
evidence regarding barriers to teledermatology and utilization practices.     
The instrument chosen in the internal evidence process must demonstrate validity to 
accurately measure the construct it is intended to measure (Langbecker, Caffery, Gillespie, & 
Smith, 2017).  In addition to an instrument having validation qualities, it must also align with the 
telehealth specialty being studied.  Caution must be exercised with adopting the instrument to a 
subspecialty.  Finding the most appropriate survey or tool to collect evidence is an important step 
and can be modified if necessary.  Adaptation of a survey can be made in a variety of ways, such 
as changing the wording, or choosing a portion of the survey; piloting the survey is an 
appropriate method for making these adjustments (Langbecker et al., 2017).   
When considering a source of data collection related to barriers to teledermatology, the 
Technology Acceptance Model (TAM) is a well-established theoretic framework associated with 
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telemedicine (Langbecker et al., 2017).  This model was developed by Davis (1989).  The TAM 
measures constructs that are relatable to providers' attitudes about using telehealth.  These 
include "perceived usefulness, perceived ease of use, attitude and intention to use" (Langbecker 
et al., 2017, p. 5).  This model does not consider elements such as barriers to acceptance of 
teledermatology, external variables or social environment (Orruño et al., 2011).  The modified 
TAM, however, according to Orruño et al. (2011), focuses on modifications to the original TAM.   
The model explicitly addresses provider receptiveness of teledermatology, and the intent to use it 
(Tensen et al., 2016).   
Since the modified TAM was used by Orruño et al. (2011) in Spain, acquiring permission 
to use it would be problematic.  The constructs were identified by Orruño et al. (2011) in 
literature and guided the development of an original questionnaire to understand the impediments 
to teledermatology or telemedicine adoption.  A brief survey was developed for use at the local 
dermatology clinic and circulated among other providers for clarity and appropriateness, before 
entering into the SurveyMonkey.com (2018) for electronic distribution.  The survey instrument 
selection and development underwent a series of adjustments to ensure appropriate questions and 
de-identification of subjects.  Faculty advised maintaining brevity with the use of closed-
answers.  The option of "explain" permitted some allowances for the detailed feedback.  
As intended, the survey described perceptions of value and facility support in conjunction 
with the providers' involvement in teledermatology.  By the advice of program faculty and the 
IRB, the instrument was revised several times, condensed from 18 questions to five, with a 
Flesch-Kincaid reading level of 8th grade (Appendix A).  The simplicity of the survey and the 
shift from research to non-research  were not expected to change the nature of the project, nor  
involve utilization patterns specific to the location site.  In general, the survey indicated the 
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overall potential for use, without informing on barriers and utilization patterns particular to the 
region. 
The subjects of this project have also changed as the early stages of the project 
developed.  Additionally, it was initially thought that only licensed providers would be surveyed.  
However, the Department Chief of ENT suggested the community health aide and practitioners 
(CHA/Ps) also be given the survey.  The CHA/Ps may or may not be using the technology due to 
the acceptance by the overseeing licensed provider, and this may impact utilization (J. Koresh, 
personal communication, February 7, 2018). 
Phase II: Validation. Examining research which supports the project is part of the 
validation step in the SMEBP (Dang et al., 2015).  There are numerous studies, literature reviews 
and expert opinions which describe and explore impediments to teledermatology utilization.  
Teledermatology adoption is discussed on a full-scale regarding barriers and suggestions to 
improve on these hindrances.   
A literature review was conducted to gather what is known about barriers to using 
teledermatology.  Additionally, information regarding the resolution of these barriers was also 
noted.  Both, telemedicine and teledermatology related articles were reviewed, and the primary 
themes were identified.  All articles involved in this literature review possessed elements 
associated with the clinical practice problem, although overwhelmingly did not address the 
issues directly.    
Strengths and limitations were easily identifiable and shaped the body of evidence 
supporting this problem focus even further.  Additionally, validity, reliability, and relevance to 
the population were also evaluated as part of the critical appraisal (Melnyk & Fineout-Overholt, 
IMPROVING TELEDERMATOLOGY                                                                                     43 
2015a).  Determining the association and applicability to the study population was the primary 
concern, although all demonstrated validity and reliability.   
Phase III: Comparative evaluation/decision making. Considering which portions of 
evidence are most applicable to the project objectives is the next critical stage (Dang et al., 
2015).  For the teledermatology utilization project, much of the evidence-based information 
pertains to cost, access to care and timeliness, greatly underpins the necessity to adopt 
teledermatology fully.  These are all uncontestable benefits of teledermatology.  Although 
literature and research findings support favorability of teledermatology in practice, little is 
known regarding the barriers within this integrated system, which are preventing providers from 
adopting this practice on a full scale.  Considering the Alaskan health care network is unique 
from those which have been studied, understanding barriers to this population must be 
considered.  The evaluation of literature was helpful in the development of the survey tool. 
Establishing a dialogue with other departments who have had success with telehealth was 
enlightening. The otolaryngology, or ENT department, has had widespread success working with 
telemedicine.  Per conversation with John Kokesh, MD, this department evaluates up to 4,000 
cases per year (J. Kokesh, personal communication, February 7, 2018).  Dr. Kokesh believes 
working with CHA/Ps is an essential part of success, as these providers are in close contact with 
patients. Using telemedicine versus face- to- face consultation can allow a department to provide 
coordinated care and allows families to be prepared before coming into Anchorage  (J. Koresh, 
personal communication, February 7, 2018).     
Phase IV: Translation/application. This step involved the transformation of evidence 
findings into modifications, execution of a plan and finally, implementation (Dang et al., 2015).   
The protocol development was a critical step in this process and will be the catalyst to practice 
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change.  Organizational approval should be met before implementing the protocol (Sparger et al., 
2012, as cited by Dols et al., 2017), and this was done through IRB and facility approval.  The 
proposed protocol was developed for both the CHA/Ps and the PCPs.  According to Dols et al. 
(2017), the protocol must direct the staff (or subjects) through the process in a stepwise fashion. 
These protocols should be conducive to both the process of patient care and the way the provider 
is thinking.  Using evidence-based material was essential to the process (Dols et al., 2017).  This 
is consistent with Melnyk's (2016) recommendations to find the best practice solution instead of 
continuing with the current practice. 
The project protocol developed was merely a reinforcement of the existing 
workflow/consult pathway, as it currently exists in this practice.  Additional recommendations 
were added for clarity.  Its purpose was to prompt the consideration for teledermatology, where it 
is appropriate.  This protocol, or process, has been translated into a visual flow for users.  Both 
licensed and non-licensed providers were included in individual and adjoining pathways.  
Eliciting input from staff dermatologists was helpful and promoted professional collaboration.  
Information was added to support project goals, and clinic recommendations were offered by 
dermatology providers and added to the guidance (Appendix B).   
Additionally, this step of the Stetler Model involves the potential of organizational 
modifications of policy (Stetler, 2001).  Using published teledermatology guidelines offers 
direction and parameters.  The American Telemedicine Association (ATA) has established 
practice guidelines which involve clinical practice, technical and administrative guidelines basis 
(McKoy et al., 2016).  These were adhered to, all the while observing the ATA clause asserting 
that providers will decide as to what is appropriate for a teledermatology on an individual basis 
(McKoy et al., 2016).  Since the objectives of the project are to provide influence and guidance 
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to changing and improving practice, not regulation, this protocol will from here on out, be 
referred to as workflow guidance.   
With information regarding provider utilization patterns and potential barriers to 
teledermatology gathered, an educational module was developed to assist, direct, and encourage 
providers to use this technology.  According to Stetler (2001), this stage considers the person, 
place, time, and purpose of formulating the plan.  The surveys were helpful in assessing learning 
needs to develop the education.  Using the educational module, not only to educate but also to 
encourage certain behaviors, was valuable especially when initiating a relationship between 
providers and the telehealth department.  As part of the educational PowerPoint, the proposed 
protocol was explained.  Melnyk (2016) noted describing the development of educational 
materials to explain each piece of the protocol improves utilization.  Indeed, the effect of the 
diffusion between providers, departments and service units will cascade over time as providers 
become more open to dialogue, suggestions, and knowledge sharing (Melnyk & Fineout-
Overholt, 2015b).   
Phase V: Evaluation. In the final stage, the project team evaluated how well the plan 
was implemented and whether the evidence resulted in meeting the project objectives (Dang et 
al., 2015).  This occurred three months post-intervention.  Aggregate data from teledermatology 
utilization was evaluated to examine the number of SAF cases and service unit utilization.  Aside 
from aggregate data, several other types of outcomes, such as survey results, educational 
attendance, practice changes, and new user data was examined to forecast the success of project 
interventions. 
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Conclusion 
The Stetler Model is a linear methodology for guiding a practitioner through an 
evidenced-based project. The teledermatology utilization project relied on each of these steps.  
This model provides a sound compass for the nurse practitioners who are involved in the project 
because of their critical thinking skills and advanced knowledge (Dang et al., 2015).  Each step is 
anticipated to carry the plan through all stages until teledermatology utilization has been 
maximized and standards of practice are improved.  
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Chapter Four: Project Design 
The purpose of this evidence-based practice change project was to improve 
teledermatology utilization within a circumscribed integrated health care system.  
Teledermatology is a well-documented modality to improve access to care (Nelson et al., 2016), 
as well as reduce the burden of cost and wait times for treatment (Campagna et al., 2017).  This 
commodity has not been practiced by all PCPs within this health care system, preventing 
uniformity of care among PCPs attending to dermatological issues.  Therefore, directing the 
course of a project through the application of a framework or model to successfully deliver an 
anticipated clinical practice change is imperative.   
The Stetler Model facilitated the execution of a plan designed to improve this 
teledermatology adoption and utilization process by establishing a method of standardized work-
flow for teledermatology consultations.  The steps of the model guided the project from 
beginning to end, with the anticipation that efforts to increase utilization will continue beyond 
the dates of the doctoral project.  Beyond these essential elements, attaining determination and 
approval through the university and project site's IRB was necessary.  The following paragraphs 
highlight the IRB function. 
Institutional Review Board 
The IRB has the responsibility of protecting the well-being of humans who are subject to 
research (Seklwitz, Epley, & Erickson, 2018).  This teledermatology project was determined 
suitable as a non-human subjects research (HSR) quality improvement project by both the 
University of Alaska Anchorage and the tertiary health care facility, therefore requiring no 
formal IRB process.  The determination of non-HSR is provided (Appendices C and D).   
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Additionally, each organization which fell under the umbrella of this integrated health 
care system was required to provide authority for the project.  The organizations, which jointly 
own the tertiary facility, also rendered authority for the project whether research or quality 
improvement.  One of these co-owners involves primary care facilities, many PCPs, and the most 
significant potential for expansion of teledermatology use.  The tertiary health care facility 
houses the hospital, specialty clinics (including dermatology), and also a large primary care 
facility for patients who reside within the urban area, which also provides health care support to 
multiple distant sites.  Many sites do not have road access to Anchorage and vary in size and 
provider staffing.  The concept proposal (Appendix E), as well as the project (Appendix F), were 
approved by several corporations.  One of the corporations supported the project, though 
clarifications to the proposal and edits in the survey were requested.  This facility does not 
employ PCPs, though does staff the tertiary care facility with many specialists.   
Subjects. The project subjects were PCPs and community health aides and practitioners 
(CHA/Ps) who have the potential to utilize teledermatology services.  Privacy was not be an 
issue since patients, individually, are not being studied.  According to Cushman (2018), the 
Health Insurance Portability and Accountability Act (HIPAA) mandates protections of 
identifiable health information, generated from institutions safeguarded by HIPAA.   For 
purposes of this project, it was not the individual patients under study, but the overall process of 
teledermatology utilization. 
Risks and benefits to subjects. Consideration of risks and benefits aligns with the 
The ethical principle of beneficence (U.S. Department of Health and Human Services, Office for 
Human Research and Protection [OHRP], 2018).  Within research, a benefit demonstrates 
something favorable associated with health and risk, without probability.  The term, risk, 
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however, when contrasted with benefit is a consideration of the potential harms (OHRP, 2018).  
Both PCPs and CHA/Ps were given the opportunity to complete a voluntary survey.  
Additionally, PCPs and CHA/Ps were given the opportunity to watch an educational video which 
included a protocol for future guidance on teledermatology use. 
Risks. PCPs and CHA/Ps were not exposed to any health risk, though there will be some 
impact on the work environment.  Inconveniences were anticipated initially, as the workflow 
guidance becomes part of the work environment.  Additionally, participation was optional.  PCPs 
and CHA/Ps were not required to complete the survey or watch the educational module.   
Benefits. PCPs and CHA/Ps benefitted from this project by acknowledging their concerns 
using teledermatology.  Experiencing reduced barriers and improved access to a standardized 
process was also anticipated.  Participants received continuing education credit on completion of 
the educational module. 
Evidenced-Based Practice Change Design 
This quality improvement design, as discussed by Melnyk and Fineout-Overholt (2015b), 
aligned well with the Rogers Diffusion of Innovations, Figure 2.  According to Zhang, Yu, Yan, 
and Spil (2015), the term diffusion is the process by which the innovation information flows 
from one person to another over time within a social system.  This theory has been applied to 
various studies regarding adoption of technology, including a cited telehealth project, internet 
health care services for family, providers, and a computerized nursing care plan (Zhang et al., 
2015).    
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Figure 2.  Rogers Diffusion of Innovations.  Schematic depicting the multifactorial elements of 
the technology adoption process. Pundak (2014). 
 
Innovation as a process involves five different characteristics.  The five specific features 
include: (a) relative advantage; (b) compatibility; (c) complexity; (d) trialability; and (e) 
observability (Zhang et al., 2015).   Relative advantage is how much the technology is perceived 
by the user to be a benefit if adopted.  Compatibility is associated with the degree the technology 
agrees with the setting.  The greater the agreement, the more likely adoption will occur.  
Complexity has to do with just how much technology is a challenge for users.  Simplicity is the 
key to more prompt adoptions.  Trialability is the feasibility to pilot a technology with limited 
obligation.  There is a better chance of acceptance with less complication.  Observability pertains 
to how significantly the advantages of the technology are recognized.  Adoption is most 
imminent at the point when understanding of the commodity's value takes place (Zhang et al., 
2015).   
This design model focuses on various types of adopters, according to their propensity to 
assume technology.  Individuals are categorized into the following classes of technology 
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adoption: (a) innovators; (b) early adopters; (c) early majority; (d) late majority; and (e) laggards.  
This model suggests greater success for change comes about by leaning on the early adopters as 
a more powerful tool for change, and then focusing on the laggards (Melnyk & Fineout-
Overholt, 2015b).     
The diffusion principal can be considered on various organizational levels. The concept 
of adopters can be applied to providers, individual health care facilities within the network and 
specialty departments within the tertiary health care facility.  Regarding providers, there are no 
official records of which providers use the service more, though it is observable that certain 
providers are more frequent users.  Individual departments of this health care facility are more 
robust users of telemedicine and, therefore, may be looked at as a model for innovation.  Within 
the health system, certain facilities are stronger users of teledermatology, while others have not 
engaged. 
Rogers Diffusion of Innovations, as discussed by Melnyk and Fineout-Overholt (2015b), 
not only promotes change in an organization but also guides individuals and teams.  Overall, 
organizational change consists of three necessary steps.  First, the vision, and the objectives must 
be identified.  The following step involves the concept of belief in the ability of the individual to 
accomplish this change.  Developing a strategy to execute the plan is the final step and should be 
specific.  Elements should involve SCOT (Strengths, Challenges, Opportunities, and Threats) 
(Melnyk & Fineout-Overholt, 2015b, p. 318). 
           Leadership. The project leader was the nurse practitioner leading this project, who is also 
a provider of teledermatology services.  This Advanced Practice Registered Nurse (APRN) 
leader discussed the project, goals, and potential outcomes with members of the project team. 
This person was also the principal investigator.  
IMPROVING TELEDERMATOLOGY                                                                                     52 
           Team members. The team members consisted of two dermatologists who also performed 
teledermatology consultation.  They helped to identify cases most appropriate to teledermatology 
services as part of the daily function.  They also provided input and reviewed the protocol or 
guidance process.  The Telehealth Program Development Coordinator was instrumental in 
providing access to data and allowing the essential telehealth coordinators to participate in the 
project goals.  The activities of the coordinators which was most helpful was assisting with 
AFHCAN access. 
           Methodology. A questionnaire was distributed to PCPs employed beyond a circumscribed 
area of the urban network.  The questionnaire asked several questions regarding utilization 
patterns and barriers to utilization, along with several items consistent with the constructs of the 
modified-TAM (Orruño et al., 2011).  The survey was helpful in understanding individual 
barriers and organizational obstacles. 
           Resources. The telehealth department at the health care facility was also a valuable 
resource, as were other providers and departments who have been strong utilizers of telehealth.  
The expertise of other dermatology providers should not be dismissed.  The ATA guidelines 
(2016) were supportive in the development of the teledermatology protocols. 
           Stakeholders. Stakeholders consisted of the corporations involved in the health care 
network and the recipients that are served.  Each corporation within the system would be able to 
spare costs and inconvenience associated with travel, and improved quality of care for patients.  
The individual providers were significant stakeholders, and naturally, clinic staff is significantly 
impacted by changes in clinical practice.  Ultimately, patients were the stakeholders most 
affected by the degree of utilization that takes place.  This service promotes timelier and more 
cost-effective care, in addition to the reduction in travel inconvenience.  
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           Change. Learning barriers preventing teledermatology from being used by providers and 
guiding direct provider utilization was a substantial change.  The Service Chief of the specialty 
clinics was in full support of the project recommendations.  Willingness to adopt the use of 
teledermatology requires ongoing diffusion among users and potential users. 
           Materials. The questionnaire/survey tool was used to gather information.  Distribution 
was obtained from a link for electronic completion.  Other materials included a protocol and 
educational module, also distributed electronically.   
           Education. The guidance on appropriate teledermatology processes was part of the 
education for all providers.  This was delivered in the form of an educational module for 
voluntary viewing.  This involved cases studies directed to both, PCPs and CHA/Ps and involved 
an understanding of the unique practice requirements of the CHA/Ps. 
          Collaboration challenge. One of the specific challenges was this project involved more 
than one organization.  The project included many independent organizations that ultimately 
receive dermatology care at one tertiary health care facility.  Resistance from service units in 
their degree of comfort in using teledermatology was anticipated as well as issues with some 
facilities not engaging in this service at all.  There were strategic hurdles to overcome.  
           Plan for project evaluation. The goal for this project was to promote an increase in the 
number of teledermatology SAF consultations over three months.  Additional anticipated 
outcomes initially considered focused on the decrease in the number of in-person visits from 
designated service units and the decrease in variation among service units regarding the number 
of teledermatology cases submitted for consultation.  Such outcomes were not possible if using 
only aggregate data but could be evaluated anecdotally, internally. 
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Data collection and analysis. Data collection methods consisted of the survey submitted 
through SurveyMonkey.com.  The information was then analyzed through the software.  
Telemedicine aggregate data was the basis of data. 
Post-intervention plans. Post-intervention plans consist of provider satisfaction surveys 
to PCPs to ascertain their satisfaction with the teledermatology service.  Understanding the 
satisfaction of providers several months beyond this project would help to understand the value 
of the protocols and education and provide a sense of direction for the future.  This may need to 
be considered every three to six months for newer providers.  This is part of the data collection 
process, as well as part of the post-intervention plan in a typical improvement process.  The 
telehealth department monitors the utilization of teledermatology and provides monthly reports 
to all departments.  The Teledermatology Provider Satisfaction survey used by the VHA 
(McFarland, Raugi, & Reiber, 2013) could feasibly be submitted three and six months after the 
project.  This utilizes the multidimensional concept of domains regarding satisfaction 
(McFarland et al., 2013) (Appendix G).  
Conclusion 
Applying the Rogers Diffusion of Innovations Theory helped improve the overall 
outcomes of teledermatology adoption by focusing on the influence of early adopters and 
potentially high performers.  Employing the project design with the SMEBP promoted a sense of 
working through stages of project development along with correlating the unique strengths and 
weakness of a telemedicine adopter.  Outlining the various components of the project and giving 
purpose and direction for each of these components, set the stage for early preparatory work.  
Awareness of potential impediments while implementing the project helped the project team take 
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extra measures to circumvent or overcome these obstacles.  Assimilation of the many nuances of 
the project objective facilitated the outcome of success and positive organizational outcomes. 
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Chapter Five: Implementation Process and Procedures 
Teledermatology provides an effective means of dermatological care consistent with that 
of a face-to-face visit (Tensen et al., 2016).  This scholarly project explored the possibility that 
applying workflow guidance and provider education to clinical practice would promote increased 
utilization of teledermatology.  Stakeholders benefit from an economic and efficiency standpoint 
which promotes quality of care and access to services.  
The transition from the literature review and planning portion of the project to the 
implementation phase required detailed planning and collaboration.  Phase IV:  
Translation/Application of the SMEBP is followed for this process.  This step is defined by Dang 
et al. (2015) as   
 “converting findings into the type of change to be made/recommended, planning 
application as needed for formal use, putting the plan into action by using 
operational details of how to use the acceptable findings, and then enhancing 
adoption and actual implementation with an evidence-based change plan” (p. 
282).   
The following chapter discusses the implementation experience with the above step to steer the 
progress as appropriate. 
Steps of the Implementation Process  
            Implementation of the teledermatology utilization project required strategic planning to 
accomplish tasks in an orderly fashion.  Much of the original project proposal was augmented to 
be more conducive to a quality improvement project.  The overall intent of the proposal was to 
promote and increase the utilization of teledermatology, not necessarily go to exhaustive lengths 
to determine and correct barriers to utilization, before instituting guidance and expectations.  
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There were, however, several areas of concentration involved in implementation, despite efforts 
to simplify the project objective.  These were as follows: (1) obtaining approval from individual 
facilities, (2) dissemination of the survey, (3) distribution of the protocol, or workflow guidance, 
and (4) dissemination of the educational module.     
           Approval. The process of implementation was not straightforward, as the IRB approval 
process and organizational approval took approximately three months.  As this Alaskan 
integrated health care system is comprised of independent corporate entities, individual approval 
from these entities was required.  Two locations provided approval, and implementation was 
done.  Two other sites were solicited for participation; however, acceptance to participate was 
not received or was received far too late into the project evaluation phase. 
           Survey. Beyond the development and approval of the survey, launching the instrument 
was much more straightforward, since it was built within the website, Surveymonkey.com.  
Intended recipients of the survey tool were positioned throughout a variety of individual 
organizations within the network, and there was no direct method of disseminating the survey 
tool to providers.  Resourcefulness and networking skills were necessary to launch the survey to 
the intended audience.  Focusing on leadership was the best method and included CHAP 
leadership and clinical management. 
The Service Chief of the primary care clinics was aware of the project and approved the 
release of e-mail addresses for the PCPs.  The survey was then distributed via e-mail.  
Additionally, the survey was also offered to one of the Community Health Provider (CHP) that 
oversees many other CHA/Ps in this corporation.  In total, the survey was initially submitted to 
51 providers, 25 PCPs (V. Corbett, personal communication, July 12, 2018) and 26 CHA/Ps (M. 
Petruska, personal communication, May 26, 2018).  After the initial survey launch, it was 
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realized this Listserv did not include an associated group of PCPs; therefore, another e-mail was 
sent out to this group with the SurveyMonkey.com link.  The survey was sent to 19 providers (B. 
Bartgis, personal communication, July 16, 2018) who represent a vital source of teledermatology 
consultations, since patients associated with this practice site are not in close proximity to the 
dermatology clinic.  Achieving access to care in this patient population is highly desirable due to 
the volume of health care recipients.  A second corporation without road access to Anchorage 
also agreed to participate in the study.  The survey link was submitted to the Vice President (VP) 
of Quality who is also a medical doctor.  From there the survey was dispersed to 241 PCPs and 
CHA/Ps within that corporation (H. Chaney, personal communication, November 15, 2018; 
November 19, 2018). 
            Workflow guidance. The telehealth department graciously crafted the flow design of the 
protocol draft which represented teledermatology expectations and standardizations.  This 
development involved several small meetings over several months.  As with the survey, the best 
method of disseminating the workflow guidance was via e-mail to the same addresses as the 
survey link.  This was distributed along with the educational module discussed below. 
           Educational module. A meeting was set up with an internet technology professional from 
another department, who aided in delivering the educational module via Adobe Connect.  As 
with the protocol, the Adobe Connect link was sent out via Listserv, and specific representatives 
to disseminate the link to view the one-hour presentation.  Participants registered online which 
enabled the principal investigator to identify the number of participants who viewed the module.  
Materials were disseminated to both participating corporations.  The providers from one of the 
corporations were given gentle reminders to at least view the module for free continuing 
education credit.  A flyer was posted in one of the primary patient clinics break-rooms.  At one 
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point it was realized that several CHA/Ps might not have received the link to the educational 
module or workflow guidance; therefore, it was necessary to reach out to respective PCPs to 
ensure materials were received.  The protocol and the educational module link were also e-
mailed to the VP of Quality, of the rural corporation, but it was questionable if this was further 
distributed to the subjects.  The link was sent individually to two interested nurse practitioners 
from the area, in anticipation that they would share and promote offering to leadership and other 
providers.  
Implementation Process 
Historically, voluntary adoption of telehealth modalities has been a goal for the telehealth 
medicine and outreach coordinators.  The steps to implementation, as discussed in previous 
paragraphs, required attention beyond anticipated administrative procedures, phone 
conversations, e-mails, and flyers.  Disseminating the project is an integral part of the 
implementation (Dols et al., 2017).  Additional activities to promote successes, as recommended 
by Adams and Cullen (2011) included: (1) reminders, (2) setting examples, (3) applying the 
evidence into the practice setting, (4) assessing compliance with the process and results, and (5) 
acknowledging when processes were successful at the bedside.     
Each stage of implementation required unique support, flexibility, and above all, 
persistence.  Periodic meetings with key personnel who supported the goals of this project, 
priority setting, and time management skills have been imperative to maintain progress and 
consistency.  Publicizing, collaborating, projecting, and networking were essential elements to 
facilitate progress.   
           Preparation. Additional actions included participating in the clinical directors meeting 
with the telehealth department which provided leverage to engage leaders in the project.  This 
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was set up prior to securing IRB and facility approvals.  This allowed for an opportunity to 
discuss the benefits of teledermatology using AFHCAN, the value for patient care, and the goal 
to involve the network organizations.  This included a brief discussion and endorsement of the 
AFHCAN mobile app.  This setting allowed an informal persuasion to use teledermatology for 
consultations from a specialist perspective.   
An early morning clinical manager meeting with the local corporation’s clinical providers 
and nursing support was attended to discuss the project, the survey and the suggestions of using 
the AFHCAN mobile app for ease of using telemedicine when the opportunities arise.  There was 
receptivity to the aspect of using the mobile application (app) which was a positive way to 
engage providers in using teledermatology in the future potentially.  To secure much-needed 
attention of the CHA/Ps, requesting a few minutes to speak at a convocation of CHA/Ps from 
rural areas in the states was a timely opportunity to talk about teledermatology.  Most of these 
CHA/Ps were either part of the health corporation in the study or received support from the PCPs 
involved in the project.  
           Collaboration. It was apparent, early on, that networking and collaboration with the 
target audience in various capacities, was critical to launching the project and getting subjects 
engaged in the project.  For example, closer involvement with the CHAP department facilitated 
the pilot of a workshop on teledermatology with community health aide (CHA) students.  This is 
planned to continue.  Additionally, providing open-ended discussions with clinic perspectives 
during a statewide telehealth video conference also raised awareness of the value and impact of 
teledermatology.  Collaboration helps to satisfy the objectives of the dermatology department, as 
well as telehealth.  The more it was discussed, the easier it became to talk about it and articulate 
expectations. 
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The discussion of the mobile app was presented to one of the primary care practices, 
located at a respectable distance from the dermatology clinic, and one of the case managers 
agreed to learn about the app and help the other providers use it.  The hope was that 
technologically savvy personnel would promote and inspire others to use the tool.  According to 
Dols et al. (2017), the addition of super users was a crucial part of dissemination.  In this study, 
super users were added at various times; such as at the onset of dissemination, and at the time of 
education, and distribution of the protocol.  Realizing who might be the champions to the 
teledermatology project was especially energizing and motivating.  
Brief meetings were also held at this same clinic with an early morning nurse group and a 
later morning provider group of about 19 providers, all of whom see patients several miles from 
the dermatology clinic.  This meeting involved a brief discussion of the project, reminder of the 
educational module available online, discussion of the workflow guidance and encouragement to 
trial the mobile app of AFHCAN.  On this day, the nurse group was far more interactive and 
enthusiastic about this tool. 
Late into the project implementation, it was realized that the pediatric group had not been 
included in the project; thus, contact was made with clinical leadership.  An early morning 
huddle provided an opportunity to discuss benefits for teledermatology.  There was clear 
receptivity to the idea.  The idea to use the AFHCAN mobile app was also presented with the 
hospitalist group, who frequently request assistance with in-person hospital consults or secure 
texting. 
Personal attention. Contacting individual providers and asking them to try AFHCAN, 
emphasizing the mobile app as a desirable method was one of the best methods to influence the 
use of teledermatology.  As providers continue to consult via phone and send images via non-
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secure methods, they were asked to consider the AFHCAN mobile app.  Because the project was 
approved by two of the health care corporations within the integrated system, there was a sense 
that it was permissible to approach providers as convenient, to use the feature.  Naturally, 
responses and receptivity varied, but most were amenable to the concept and willing to use the 
mobile app.  Appealing to providers' sense of duty to provide excellent care efficiently was a 
catalyst for compelling providers to accept this method of sending consultations. 
           Time management. Another part of the implementation process was developing a reverse 
timeline.  Since the depth and character of the project has changed and implementation delayed, 
considering the timeline from a reverse standpoint was necessary to allow for delays, 
interruptions, and complications.  Securing a minimum of three months of data post-intervention 
was ideal for determining if education and protocol implementation promoted increased use of 
teledermatology.  Although it was not feasible to incorporate many of the network facilities in 
the project, in time, with evidence of successes with a few regional facilities, the project will 
continue in some form or fashion until the adoption of teledermatology and efficient processes 
are part of the typical daily clinical workflow.  
Challenges and Barriers to Implementation 
One of the significant barriers to the implementation and success of the implementation 
was getting buy-in from the participants.  Though there seemed to be a steady flow of survey 
responses (likely because the survey was brief), capturing providers' interest in a technology that 
is mostly voluntary was no easy task.  The tools implemented to improve provider adoption, the 
workflow guidance, and educational module, were not overwhelmingly embraced, despite the 
educational credit available at no extra cost.  There were 12 documented attendees of the 
educational module. 
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In addition to the need for provider engagement, working with a health care facility from 
a distance was a challenge due to the unfamiliarity with the organizational structure.  Secondly, 
project materials may not be dispensed as anticipated.  Thirdly, interfacing with clinical 
personnel was not feasible as it was with providers in closer proximity.            
Another area of potential conflict is the continued changing of the electronic health 
record (EHR) among various sites within the organization.  Historically, AFHCAN has been the 
primary vehicle for SAF teledermatology; however, since the EHR has become instituted, this 
pattern is beginning to change.  This use of various EHRs has created inconsistencies in how 
service units are requesting consults and referrals, and thus, has made for secondary pathways for 
teledermatology via e-mails and secure texting.  This problem, however, provided an opportunity 
to strategize methods to engage providers in uniformly using teledermatology in order to 
eliminate confusion and promote uniformity.  Recognizing the difference between consultation 
and referral is also problematic in EHRs and with providers.  Modifying a referral into a consult 
is a challenge when using the EHR.  With AFHCAN, however, it is relatively simple to make 
this adjustment and bill for consultative services.  Understanding the impact and components of 
referral and consultation was discussed in the educational module. 
Lastly, one of the significant barriers to the implementation of the project is that it could 
not involve the entire health network simultaneously.  Individual facilities must approve the 
participation and would have a process to follow.  However,  an essential sample of the system 
was targeted in this project, and lessons learned can later be applied as the expansion of 
teledermatology is pursued.  There are likely a number of political, cultural, and administrative 
barriers that may result in a barrier to adoption, and future research could help identify important 
strategies for improving teledermatology utilization. 
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Considerations 
Though one of the entities involved in the project has not been historically receptive to 
AFHCAN, involvement in the project was very encouraging.  The organization would need to 
support the use of teledermatology and eventually understand the positive impact of adopting 
access-to-care technology.  It is necessary to proceed cautiously to avoid unnecessary loss of 
gains.  This project can potentially change this practice and facilitate easier access to care for 
those who live at a distance from the tertiary facility. 
On the other hand, the other corporation involved in the project has used the system 
significantly in the past but have ceased actively using the resource.  The reasons for the decline 
in utilization is not clear, but some of the reasons suggested were: (1) the dermatologist had 
retired, (2) providers may not have been aware that cases could still be sent for the covering 
nurse practitioner to review, (3) the corporation changed from a paper medical chart to the 
electronic health record, and (4) difficulties with EHR and AFHCAN integration may have 
resulted.      
Aside from organizational considerations, one potential limitation of this project is the 
likelihood that there is a shift in wait times for this clinic since there are now three providers 
working consistently.  An increase in the number of teledermatology cases could also be 
attributed to the heightened awareness in the clinic to improve the process.  Providers requested 
teledermatology consults when appropriate, especially when reviewing incoming referrals.  A 
rise in consultations may be the result of increasing awareness of teledermatology, potentially 
due to the existence of this project and the perpetual discussions pertaining to such. 
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Conclusion 
Though the implementation of the Teledermatology Utilization Project suffered delayed 
execution, the intervention was delivered and integrated into the population of providers to the 
greatest extent possible given elements of resistance, distance, and complexity.  The initial tasks 
and reinforcements have since been activated, and ongoing efforts to engage providers' interests 
in teledermatology have ensued.  Continually laying the groundwork, performing fieldwork, and 
promoting teamwork ensured a thorough implementation with much potential for future goals for 
improvement.  Finalizing details, collecting surveys, and keeping all project stakeholders 
informed have been equally important and challenging objectives.  Keeping the end goals in 
mind to reach a successful practice change and foster the momentum of continuous quality 
improvement is an important objective.   
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Chapter Six: Evaluation and Outcomes for Practice Change  
Teledermatology has been an evolutionary technology with questionable degrees of 
adoption and acceptance among PCPs.  This scholarly project introduced a practice change 
initiative from a clinical perspective.  Though the Alaskan health care system houses a prominent 
telehealth department that is currently practicing outreach, support, and education, there are 
varying degrees of individual and regional telehealth participation.  One exception to the 
implementation plan was only a small fraction of health care organizations under the network 
participated, due to the inordinate amount of time it would require gaining approval of each  
facility site.  Phase V: Translation/Application of the SMEBP was followed for this process 
(Dang et al., 2015). 
Outcome Measures 
Selection of outcome measures was significantly adjusted from the original plan to one 
primary outcome measure: the trend in teledermatology consults generated for areas outside of 
the immediate urban area.  Teledermatology modalities, in general, are directed for these types of 
patients for improved access to care.  There were variables identified that could potentially 
influence this outcome measure other than the specific implementation interventions.  These 
include: (1) coordinated efforts among dermatology providers to encourage consults as a 
substitute to in-person referrals, and (2) increased awareness of support staff to request images 
when referrals are submitted.    
For outcomes data, de-identified aggregate data was examined monthly.  This was done 
by reviewing the summation of billed encounters during monthly meetings with the telehealth 
coordinator.  The analysis process is a visual application in chart form, via Excel.  Information 
derived from the survey was processed via SurveyMonkey.com matrix.  This involved response 
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selection and reviewing free-text input.  Other outcomes will be presented through discussion in 
sections below. 
Although outcomes are expected to fluctuate and change over several months, the overall 
trend in utilization is essential to evaluate.  Unfortunately, utilization changes may not be evident 
for many months to come.  Many areas can be assessed to ascertain project effectiveness, which 
impact practice for further provider participation in teledermatology.  In addition to aggregate 
data, these areas include survey analysis, educational attendance, new user information, and 
changes in other departments; all of which suggest anticipated progress and future impact.  
Data Analysis 
For outcomes data, aggregate data was examined monthly with the telehealth coordinator.  
Only deidentified summations of encounters were reviewed.  The analysis process is merely a 
visual application in chart form via Excel.  Information derived from the survey was processed 
via SurveyMonkey.com matrix.  This involved response selection and reviewing free-text input.  
Other outcomes will be presented with a simple discussion.   
Aggregate data.  Aggregate data is maintained and monitored by the telehealth 
department.  There may be several ways to view the aggregate data, teledermatology SAF data 
over three months was compared with the same months of the previous two years. The project 
was mostly implemented between the last part of June and the beginning of August, 2018.  Data 
is presented below in graph format, see Figure 3. 
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Figure 3. Growth over three months with comparisons of three years. August to October, 2016 to 
2018. 
 
Aggregate data represented total AFHCAN cases received from all network sites, 
although to clarify, only two sites were included to participate in the survey, workflow guidance, 
and education module.  The dermatology providers observed the process of the workflow 
guidance for all incoming queries, which was applied to all corporations in the network.  This 
was the only feasible method of managing this project since it was not feasible to involve all 
health corporations in the project.  As mentioned previously, all dermatology providers had 
heightened awareness and vigilance to request teledermatology consults instead of referrals if it 
deemed appropriate.  Support staff also became more stable and cohesive during this project,  
requiring providers to send images along with referrals.  This offered the opportunity to convert 
referrals into SAF consults.  Additionally, it is important to note the outcome data reflects more 
August September October
2016 26 12 23
2017 33 23 28
2018 43 40 73
26
12
23
33
23
28
43
40
73
Telederm SAF
2016 2017 2018
IMPROVING TELEDERMATOLOGY                                                                                     69 
than those outside of the primary urban area because providers who have begun to adopt 
teledermatology practices are occasionally using them for local patients. 
Survey.  The survey consisted of two demographic questions and five core questions 
involving general utilization information.  After approximately 12 weeks, 70 responses were 
received and evaluated to develop the educational module.  It was determined that there would 
be 311 eligible respondents between the two involved health care corporations.  Determining the 
eligible PCPs and CHA/Ps was done by asking key personnel including the VP of Quality from 
one corporation and the CHP and Service Chief from another.  Comments were useful in gaining 
insights into barriers and impediments.  According to the analysis, most of the survey 
respondents were providers in rural areas.  Although most respondents did not use 
teledermatology, most respondents felt that teledermatology was appropriate for the worksite. 
The survey continued to be available to groups for ten weeks who later were able to 
respond; and to date, there have been 73 responses.  Bar graphs extracted from 
SurveyMonkey.com illustrate responses to the five core questions and two demographic 
questions (Appendix H).  In addition to the concrete multiple-choice answers, some responses 
were free text and can be used as evaluative information.  SurveyMonkey.com word analysis was 
used to review common themes in the "comments" section.    
              In addition to the multiple-choice questions, there were 155 free text comments.  These 
were evaluated via text analysis, which is a list of the most commonly used words in the 
responses.  Table 2 provides some of these common words per survey question. 
Table 3 provides sample responses using keywords obtained from the comments. 
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Table 2   
 
Text Analysis for Survey Responses in Order of Frequency 
 
Question  Frequent Text 
How often have you used teledermatology in the last six months? 
 
 Use * Know* Case* Available* 
Needed 
Does teledermatology make your job easier when caring for patients? 
 
 Used * Never * Help * Cerner * 
Pictures 
Do you feel that the process of performing teledermatology is 
challenging and keeps you from using it? 
 
 Use * Working * Carts * AFHCAN 
* Never 
Do you feel that teledermatology is suitable for your work area  Used * Patient * Teledermatology * 
Anchorage * Pictures 
Do you feel supported in the use of teledermatology by your job?  Use * Supported 
 
 
Table 3 
 
Free Text Survey Responses 
 
Text                      Responses 
Know “I didn’t know this was an option” 
“I didn’t know it was available”   
 
Patient “Having the ability to consult enhances any patient encounter” 
“Yes a lot, the providers can see the pictures of our patients and help diagnose and treat” 
 
Working “The AFHCAN equipment is not overly complicated to use it is just slow and adds unneeded 
work” 
“Once the carts are working they are pretty straight forward on how to use. That being said i 
have never contacted or tried to contact dermatology with the carts or otherwise” 
 
Pictures "Teledermatology is very suitable, as we are able to send a picture of a derm patient with the 
history provided to get a diagnosis and plan in place" 
“We get many pictures sent in to us ("RMT" from the villages), so we are fairly used to 
trying to diagnose from afar” 
 
Used “If it was simple and fast I would use it. I have used it once in 5 years  
7/11/2018 11:29 AM” 
“Teledermatology is useful because dermatology issues can be hard to describe but, not 
through AFHCAN” 
 
Educational module.  This module was developed using information from literature, 
prior aggregate data, and survey responses.  Out of 311 eligible participants, 12 participants 
viewed the educational PowerPoint.  It was hopeful that more providers and CHA/Ps would have 
participated in this activity.  Participants demonstrated the intention to use teledermatology as a 
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result of the education and largely demonstrated comprehension of teledermatology basics based 
on the post-evaluation. 
New user data.  Thus far, several PCPs from one of the corporate health facilities have 
received or refreshed their username and password to AFHCAN.   Examining total access 
numbers are not practical as many providers were assigned usernames in the past but did not use 
them.  Some have gained or regained access, with the intent to use.  Each new case represents a 
motivation to send proper consults that are easily billable for the dermatology provider and 
remain HIPAA compliant.  Having providers send cases, however, has been a gradual process.  It 
should be emphasized that providers at one of the two corporations were not previously users of 
AFHCAN before this project, except possibly in remote rural areas.  Most providers have been 
assigned usernames and passwords but did not have the direction or guidance to use the 
technology.  An increasing number of providers have been solicited to trial AFHCAN mobile, 
which is increasing the receptivity for use. 
CHAP training.  One-hour long workshops have begun with the training sessions for 
CHA/P, who are uniquely positioned to initiate teledermatology activity through the preferred 
software.  This was not part of the actual implementation but became an evolution from the 
Clinical Concentration course with the CHAP department.  Working with the CHAP department 
was an excellent way to promote visibility, and there is a current plan in place to continue to 
offer this workshop. 
Results 
As data collection is an ongoing process toward the goal of quality improvement, the 
results of this project are preliminary and should be examined at periodic intervals.  The survey 
response was low, approximately 23%.  Responses from the survey multiple choice questions 
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indicated most individuals did not have experience with the software and could not form 
overwhelming positive opinions.  The largest response groups noted per question: 
1.  How often have you used teledermatology in the last six months?  Teledermatology was 
rarely or never used in the previous six months (81.43%);   
2. Does teledermatology make your job easier when caring for patients? Teledermatology 
did not make work easier (32.26%);  
3. Do you feel that the process of performing teledermatology is challenging and keeps you 
from using it? Respondents sometimes felt the challenge of teledermatology was a barrier 
(20%); 
4.  Do you feel that teledermatology is suitable for your work area?  Respondents did not 
feel supported by the job in the use of teledermatology (17%); and  
5.  Do you feel supported in the use of teledermatology by your job? Most respondents most 
felt it was suitable for the job setting (88.71%). 
With new processes in place, the modalities of teledermatology are more likely to be 
committed to practice, or at least considered.  These processes include improved communication 
and relationships between PCPs, dermatology providers, and telehealth coordinators, along with 
modifications in training with the CHAP department.  Not only are individual providers 
demonstrating an interest in AFHCAN, but entire groups of providers are also taking an interest 
in consults via the software.  From a clinician standpoint, dermatology providers are exercising 
more significant control of in-person referrals due to vigilant screening and suggestions for 
AFHCAN consults as appropriate.  Overall, there has been a notable increase in consults to date, 
since actively promoting teledermatology within the designated health corporations.       
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Conclusion 
Project efforts resulted in an increase in teledermatology adoption and utilization. 
Aggregate data provided acknowledges a substantial increase, particularly in the third month of 
data collection.  This would likely only have been accomplished by the individual components of 
this quality improvement activity, but also by specifically marketing a simpler method of using 
teledermatology software; i.e. the mobile app.  The results are focused on a relatively small 
number of cases overall, though each month of the project yielded a higher number of cases then 
year prior.  The results confirm that concentration on groups with various strategies and mindful 
evaluation of provider requests can enhance the adoption of the teledermatology process. 
Data collecting in a project such as this can be tenuous, and merely a reflection of a much 
larger development.  Data is fluid and varies significantly from month to month for many 
reasons.  Alaska is well known for subsistence lifestyles and weather fluctuations.  Persistent 
attention to incoming referral requests can reduce a percentage of in-person visits that are not 
necessary, yet it does not account for the many dermatological conditions which may not be 
considered for assistance.  Thus far, new provider engagement appears to be the most significant 
indicator of teledermatology expansion.  Continual marketing and networking with regional 
health facilities, in some capacity, is critical for practice changes in dermatology.    
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Chapter Seven: Implications for Practice 
 
Throughout the project course, it was evident that the Doctoral of Nursing Practice 
(DNP) Essentials were supported in numerous ways.  These fundamentals published by the 
American Association of Colleges of Nursing ([AACN], 2006) affirms the proficiency and 
qualifications of advanced nurse practitioner regardless of capacity employed.  Specific 
categories are more greatly expressed, depending upon the unique and expert role of the 
advanced practice nurse and the focus of the project.  The DNP Essentials are discussed below in 
relation to the Teledermatology Utilization Project.    
Essential I: Scientific Underpinnings for Practice          
This concept asserts the management of clinical matters demands the stability and 
support of the sciences (AACN, 2006).  Because theories are an essential product of nursing 
science, the DNP must be aware of the ongoing developments of such approaches to positively 
affect issues in health care while instilling practice methods for the future.  Several disciplines of 
science are incorporated in nursing science, which frames the development of middle-range 
theories and concepts to guide nursing practice (AACN, 2006). 
The social sciences, for example, acknowledge a relationship between health care 
providers and internet technology.  The connection may be one of conflict; however, nursing 
practice models serve as guides to the practice change and quality improvement (Wagner‐
Menghin & Pokieser, 2016).  Roger’s Innovation of Diffusion model aligns with the use of 
adoption of technology, based on a theory by Everett Rogers.  This theory involves the adoption 
of innovations and the rates at which individuals do this (Melnyk & Fineout-Overholt, 2015b).  
The essence of this model was evident during the progression and fulfillment of the project and 
will be relevant as the impact of the interventions continues. 
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Essential II: Organizational and Systems Leadership for Quality Improvement 
and Systems Thinking            
This concept assumes the DNP has attained the necessary knowledge to exercise quality 
management in health care (AACN, 2006).  This involves awareness of productivity 
requirements while committing to population health needs.  It also suggests the ability to 
improve the standard of care while focusing on organizational goals.  Proficiencies in cost-
containment, coordination of care, and risk assessment are DNP necessities, as well as 
knowledge of methods of care delivery (AACN, 2006).  
Kirkpatrick and Weaver (2013) discuss research survey results regarding desirable 
fundamental competencies of graduates of the DNP program as a reflection of the capstone 
project.  Some of the cited qualities were leadership promotion, clinical acumen, and managerial 
capacity.  Furthermore, the ability to initiate best practice measures in the health care system was 
an expectation (Kirkpatrick & Weaver, 2013).    
With the above points in mind, expanding the role of acceptance of teledermatology in an 
extensive health care network, particularly with regions that have been low use or non-use, aligns 
directly with the principals of this essential.  Leadership has been strongly required to help carry 
these efforts forward, with an emphasis on meeting the needs of the population.  Appealing to 
leaders and groups have been essential in moving toward this objective, though resistance 
persists and will so beyond the scope of this project.  
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice  
Scholarship Education 
           This essential embodies the doctoral level nurse's research capacity to process known 
evidence, produce new information while applying these emerging concepts into health care 
practice (AACN, 2006).  This entire essential involves (1) processing literature, (2) developing 
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an approach to evaluate practice, (3) establishing modes of improvement, (4) using results to 
further improve practice, (5) understanding resources for collecting a broad scope of information, 
(6) assuming an expert role in research and knowledge acquisition, and (7) sharing what has been 
learned from the experience to improve care (AACN, 2006).    
          The DNP is focused on applying a solution to an identified health care issue (Leibold, 
2016).  Applying the SMEBP was the appropriate framework to approach the need for health 
care delivery.  This project aligns strongly with the process of clinical scholarship and quality 
improvement, via processing of literature, formulating a project plan, and executing the plan 
(Dang et al., 2015).  Beyond this, the process involved a continual reassessment of project 
direction and effectiveness, while employing strategies to reapply new information — the project 
allowed for an emergence of other practical ideas to consider for future project work.                
Essential IV: Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Health Care                                              
         This essential realizes the importance of technology in improving health care and 
associated systems (AACN, 2006).  Gaining perspective of the appropriateness of various 
technology resources is a DNP responsibility and a key aspect of care.  Though straight forward 
in concept, Essential IV covers a broad scope of skills, from creating programs, appraising 
information resources, and providing oversight and ethical guidance in areas pertaining to 
information management (AACN, 2006).   
Internet technology involves instruments which empower cognitive abilities and 
ultimately improve work contentment and interactions with others (Wagner-Menghin & 
Pokieser, 2016).  Health technology encompasses teledermatology, and nursing leadership has an 
important role to play in this field of health technology while managing the human aspects,  
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benefits, and fiscal responsibilities.  Furthermore, nursing leadership must ensure nurses are 
competent and ethical in the use of this technology.  There are many areas within the scope of 
technology that nurses must be exposed to while keeping in mind there are positive and negative 
aspects of technology (Raman, 2017).  This project was integrally associated with aspects of 
internet and health technology.  Telehealth and teledermatology require internet capability and 
competent, reliable communications support to engage others in the resource.  It also involves 
being able to connect on a personal and professional level with providers, which has been key to 
cultivating genuine interest and desire to augment health care delivery. 
Essential V: Health Care Policy for Advocacy in Health Care 
This valuable requirement pertains to the role of the professional nurse’s influence on 
health policy at a multitude of organizational levels (AACN, 2006).  This essential quality is 
central to the fate of health care practices.  The DNP can use sound judgment and leadership 
skills when evaluating policies and pioneering for improved practices, while teaching, team 
building, and inspiring.  Serving in a variety of capacities with multiple organizational agendas 
impacts health care policy positively (AACN, 2006).    
One of the goals of the project was to develop workflow guidance to help providers 
visualize the consult and pathway process.  Promoting the voluntary use of methods of health 
delivery may eventually lead to change in the dermatology practice, and eventually, become a 
standardized approach.  An approach to policy development on a system-wide scale should look 
to professional organizations for direction.  One such organization is the American Academy of 
Dermatology (AAD), which promotes the use of telemedicine in dermatological care, yet 
supports the provider's right to choose whether the care should be in person or virtual (AAD, 
2017).  A desirable policy may be, at very least, to ensure providers have access to the use of 
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teledermatology methods.  Providers are often faced with the task of being stewards of hospital 
resources and patient advocates.  
Essential VI: Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes   
This important DNP essential implores the need for the DNP to be prepared to work as a 
team member professionally (AACN, 2006).  This essential is also one of the most common 
threads of the entire project.  The interprofessional collaboration was an active and common 
theme evident throughout the entire project.  Excellent communication and networking skills in 
several professional, quality focused areas are essential, including a focus on practice policy and 
standards.  The DNP must show leadership capabilities in this area with practice and 
administrative challenges; as well as encourage groups to unite toward common goals in the 
health care arena (AACN, 2006). 
The collaboration is discussed by Kelley and Littman (2005), as a persona, the 
Collaborator, which is one who can unite individuals beyond their comfort zone to accomplish 
tasks.  They can flexibly work through departmental restraints to influence individuals and 
groups (Kelley & Littman, 2005).  The substance of this project was based on the foundation of 
collaboration with other individuals and departments, specifically the Telehealth and CHAP 
department.  
Essential VII: Clinical Prevention and Population Health for Improving the Nation’s 
Health 
This necessity explores the role of the graduate DNP in a leadership capacity.  In this 
focus, the DNP integrates evidence-based health care interventions for the betterment of larger 
groups (AACN, 2006).  Mentioned earlier in this paper was the tremendous cost burden 
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associated with skin disease in the United States.  According to Lim et al. (2017) over 25% of 
American citizens, nearly 85 million, suffer from a skin condition.  Based on medical claim 
reporting, this number is more than those with cardiovascular disease and diabetes combined and 
may be considered a public health issue. 
Interestingly, skin disease prevalence is likely underrepresented.  Furthermore, when 
considering population health another point made by Lim et al. (2017), is that the U.S. senior 
population, aged 65 and older, is projected to increase significantly with an unchanging 
physician supply.  This demographic shift will yield a disparity in dermatology coverage, most 
noted in the rural areas (Lim et al., 2017). 
This project is firmly based on the power of technology as a means of caring for the 
underserved populations and providing access to care.  Maximizing the use of established 
resources should ameliorate the impact on the population demographic shift.  The effective use 
of teledermatology should result in cost-effective, timely, accessible, and quality dermatological 
care. 
Essential VIII: Advanced Nursing Practice    
This final essential recognizes the DNP as having acquired a level of competence in a 
particular area of nursing (AACN, 2006).  Several areas of science are recognized as necessary 
in the DNP, beyond skills cultivated and regardless of the associated specialty.  Though specific 
domains of science support the area of interest for the advanced practice nurse, several important 
attributes are significant markers of the DNP graduate.  For example, the DNP can evaluate and 
comprehend the scope of problematic health concerns in a population and develop interventional 
methods to address health issues.  The DNP also possesses the ability to successfully advance 
quality improvement objectives based on and supported by evidence and provides the necessary 
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leadership to foster growth in other nursing professionals.  Additionally, the ability to apply 
critical thinking skills to diverse issues and entities associated with health care while providing 
counsel to those persons in need is a noteworthy characteristic (AACN, 2006). 
Efforts to make positive change despite known or perceived organization resistance was 
somewhat challenging but energizing in the early stages as incremental changes associated with 
adoption occurred.  Merging clinical expertise with the general provider population, while 
integrating the support of the telehealth department, helped impact provider openness to engage 
in a contemporary modality of health care delivery.  The impetus to positively work toward a 
shift in health care delivery was not likely positive without the guidance of the DNP process. 
Implications 
As noted above, each of the eight DNP Essentials can be applied to this project.  The 
essentials are a guide of the minimal DNP graduate necessities, yet most of the learning elements 
have been uniquely manifested by the originality of the project for each DNP student.  The above 
essentials are an elaborate list of requirements of the DNP program which serve to reinforce the 
ideologies of the DNP scholarly journey.   
According to Volkert and Johnston (2018), DNP students may have concerns which 
parallel their doctoral counterparts from other disciplines as the DNP capstone can be 
problematic beyond the typical issues.  These concerns include: (1) lack of clarity regarding the  
program requisites, (2) issues with faculty involvement, (3) the focus skill and interest for the 
student, and (4) the layout of the courses, according to findings by Grossman, Kazer, Moriber, 
and Calderwood (2016).  There is, apparently, a knowledge deficit on both the student and the 
educator's part to the real necessities of the program and process, yet essentials get to the heart of 
the academic program and provide a basis of consistency.  If all other issues are unclear, or 
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unsupported, the essentials should guide the DNP student to the completion of a robust doctoral 
program. 
Limitations 
With such a program, it is critical not only to identify the essentials that are readily 
evident in the project process, but also to be aware of areas that may need special attention as the 
lack of a natural influence over the project progression.  It could be more valuable to the DNP 
student to internalize and consider these essentials prior to commencing project work in order to 
synchronize the project themes and efforts with requirements, rather than to match the essentials 
with incremental milestones experienced along the project pathway.   
Conclusion 
The DNP educational track is theoretically composed of eight basic areas of aptitude and 
skill as well as exposure to specific practice domains (AACN, 2006).  Each DNP essential 
reflects an independent element of importance contributing to the integrity of the scholarly work.  
Understanding the role of each DNP essential provides a sense of value and validity to the efforts 
made to improve practice in an organization or the community.  Without these essentials, there 
would be insufficient substance to meet the value of an impactful quality improvement project.   
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Chapter Eight: Summary and Conclusion  
Teledermatology is a tool that can enhance the dermatological care of individuals across 
the lifespan, particularly for those populations where access to care is challenged.  Developing 
strategies to promote system-wide acceptance and adoption required carefully reviewing 
evidence, selecting a framework, choosing the model, proposing a plan, and then formulating the 
process.  Engagement with the Telehealth Department was necessary though many other 
individuals and departments were instrumental in the project success.  
The objective of this project was to promote the use of teledermatology by identifying 
barrier issues present in the health care system and developing a process for improvement.  A 
pre-implementation survey identified knowledge gaps regarding the use of teledermatology 
technology.  This led to the development of a workflow pathway designed to prompt provider 
initiative and submission of teledermatology cases through the established health care network 
software AFHCAN.  In addition to the workflow pathway, an educational module delivered 
support and education regarding teledermatology, including introductions to the dermatology 
staff, identification of barriers to teledermatology, the consultation process, and support for 
decision-making.  Providers (PCPs and CHA/Ps) unfamiliar with AFHCAN were encouraged to 
use the HIPAA compliant, mobile application to get started in using teledermatology processes. 
The mobile app was used as a vehicle in attracting provider interest. 
The two organizations within the health system involved in this project agreed to allow 
providers to participate and each of these were rare users of AFHCAN.  Targeting these two 
corporations was both productive and challenging. The primary methods of distributing materials 
were through e-mail; however, opportunities to present information to a live group occurred 
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periodically.  The telehealth coordinator(s) were integrally involved with facilitating provider 
log-in support.      
Engaging with other individuals, such as the hepatitis internet technology support 
specialist, CHAP medical director, and nurse educator was also necessary.  Optimal receptivity 
for the use of teledermatology was enhanced when the opportunity to promote the service was 
identified on various occasions, including connecting the provider with the appropriate telehealth 
coordinator initiate access to AFHCAN.  Surprisingly, many individuals knew little about 
AFHCAN, though this application has been part of the health system for many years.  Although 
it was challenging to reach the CHA/Ps with the workflow and educational module, a process of 
discussing teledermatology was offered through the CHAP classes since the project was 
initiated.           
Another example which promoted receptivity of the teledermatology process included 
encouraging use of the mobile app, which is simple to use and acceptable by many providers.  As 
Zuo, Guo, and Rao (2013) note, smartphones are becoming more and more commonplace in 
medical practice.  Not only is the smartphone overall handy to carry, but the quality of imaging 
and hardware have also improved dramatically in recent years.  Additional factors which 
promote receptivity include increasingly efficient internet access, lack of need for a stationary 
computer, as well as the fact that teledermatology is inexpensive (Zuo et al., 2013).  As Zuo et al. 
(2013) suggest, one method to increase the use of teledermatology through a mobile app is to 
incorporate training into education programs for those in the health care profession.  This 
practice is something which could be considered for inclusion in the future, as part of the new 
provider orientations in primary care.  
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Though the project was specifically geared toward providers for rural patients, it was 
interesting that some providers also used the mobile app for in-town patients.  This was an 
unexpected outcome as these same providers often care for out-of-town patients and can 
encourage assigned CHA/Ps to use the software as well.  In addition to patient groups discussed, 
outreach for teledermatology also was expanded to other special groups, including women seen 
by OB/GYN providers (including certified nurse midwives), pediatrics, veterans, and homeless 
adult and youth. 
Overall, the range of individuals potentially influenced by this purposefully directed 
project is extensive, considering the vast geographical landscape of Alaska.  Because of the 
widespread population, this project has a tremendous opportunity for endurance and 
sustainability.  Focusing attention on one or two organizations at a time, applying a needs 
assessment, guidance, and education will bring continued success to the adoption of 
teledermatology, increasing access to care, improving quality of care, and decreasing health 
disparities.  Though there were marked successes with adoption and acceptance, there was also 
resistance and objection apparent during the implementation phases; therefore, more 
considerable effort to promote the use of the teledermatology was spent on receptive audiences.    
Implication for Future Practice          
Although this project was directed toward the expansion of teledermatology utilization, it 
beckoned an obvious need to collect data which identifies rationales for the avoidance of the use 
of the technology and why acceptance is sluggish despite evidence of the benefits.  A health 
network such as this is conducive to such research, as there are many corporations which fall 
within the network that use the tertiary site as the centralized specialty care center.  The literature 
supports the experience of the Teledermatology Utilization Project in that there is identified 
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resistance to technology adoption across many fields.  Given the range of stakeholders, including 
the recipient, provider, specialty provider, and an affiliated organization, there is value in 
addressing the experiences of this project and engaging in research which explores provider 
motivation and learning needs.  For example, what would cause one provider to readily accept an 
opportunity to receive treatment help from an accessible dermatology provider, as opposed to 
one who relied on self-knowledge and other resources repeatedly before reaching out for the 
expertise of an experienced specialist? 
An interesting concept for a future project, maybe to evaluate the role of teledermatology 
for patients in the urban area.  Using the technology, whether in a rural or urban area could 
reduce no-show rates, as well as save time, money, and avoid delays in treatments.  Most of the 
current referral base is generated from the local, urban area, and quick consultation via 
teledermatology might reduce the need to schedule appointments for new patients, whose 
conditions might easily be handled by a brief expert consultation. 
Additionally, studies involving descriptive data would be helpful in determining the 
threshold at which providers will seek out help.  There is extreme variability among providers 
regarding the point at which patients are referred to dermatology.  Understanding the comfort 
levels and tendencies of providers would be helpful in determining teledermatology expectations.    
Lastly, investigating the differences in teledermatology utilization among the different 
regions and tribal affiliations might bring about the most significant knowledge improvement 
pertaining to barriers and the adoption of teledermatology.  Gaining insights into various patterns 
within institutions and geographic locations can help telehealth leadership develop educational 
and training tools and apply strengths to areas which demonstrate less inclination for use.  In 
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time, it is hoped there is an equal distribution of teledermatology consults throughout the 
network, based on population and that accessing this skill is routine and commonplace.     
One area that may change as more providers adopt teledermatology is dermatology staff 
may have to expand or be modified to accommodate the rise in cases.  Currently, there is little 
time devoted to these cases as they can generally be managed between patients or during gaps in 
the schedule.  In time, dermatology providers may need to be incentivized to do as many consults 
as possible, and likewise, PCPs who send teledermatology cases, could be informed periodically, 
how much money was saved with this method concerning direct and indirect costs.  Utilizing 
resources designed to bring specialty care closer to primary care of all regions and populations is 
one step closer to reducing health disparities in underserved communities. 
Personal Reflection 
The impact of connecting providers with technology was a powerful indicator that the 
Doctoral of Nursing Practice paradigm could impact organizational leadership and health care 
delivery.  The role of the advanced nurse practitioner can easily become obscured by the public 
recognition of the physician and role confusion can arise.  It is valuable to participate in 
collaborative changes that will have a lasting effect on the health care network and which can 
continue with continued planning and dedicated efforts.  This project has helped inform future 
endeavors, regarding organizational skills, networking with stakeholders, educational 
preferences, and technology support.   
Conclusion 
Findings indicate practice changes can occur with effort on the part of a motivated 
person, however, without the authoritative direction of management, changes come about slowly.  
If indeed there is a clear indication that overall teledermatology is profitable to users as well as 
IMPROVING TELEDERMATOLOGY                                                                                     87 
patients, then it is much more likely to meet the approval of management who are supportive of 
the practice change.  Likewise, it is also necessary for leadership to accept the value of 
teledermatology services as a means to facilitate expert, specialty care.  To maintain ongoing 
expansion, it is imperative that educational needs be periodically re-evaluated, updated, and 
presented in different formats to ensure skin conditions are mindfully addressed about time, 
location, treatment options, and financial feasibilities. 
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Appendix A 
 Teledermatology Utilization Survey 
Table A-1 
Survey for Teledermatology Utilization 
 
This consists if two demographic questions and five core questions to determine teledermatology 
perceptions and needs. 
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Appendix B 
 Workflow Guidance 
 
 
Figure B-1. Workflow guidance to direct the recommended communication pathways of consults 
and referrals. Represents all levels of providers supporting the care of patient.  
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 Appendix C 
University IRB Determination 
 
 
 
 
 
IMPROVING TELEDERMATOLOGY                                                                                     100 
Appendix D 
Institutional IRB Determination 
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Appendix E 
 Concept Proposal 
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Appendix F 
 Participating Corporate Approvals 
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Appendix F (continued) 
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Appendix G 
 Teledermatology Provider Satisfaction Survey 
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Appendix H 
Survey Response Data 
1: How often have you used teledermatology in the last six months?   
 
 
2: Does teledermatology make your job easier when caring for patients? 
 
3. Do you feel that the process of performing teledermatology is challenging and keeps you from 
using it?   
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Appendix H (continued) 
4: Do you feel that teledermatology is suitable for your work area? 
                                                                     
5: Do you feel supported in the use of teledermatology by your job? 
 
6: Location 
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Appendix H (continued) 
7: What is your job title? 
 
Figure H-1.  Results from SurveyMonkey.com 
Each question represented in  bar graph visual by percentage of respondents. 
 
 
 
 
